FRANÇOISE BAYLIS, CM. ONS, PhD, FRSC, FCAHS

University Research Professor Dalhousie University Phone: 902.471-0487 (c) P.O. Box 15000 Email: [email protected] Halifax, Nova Scotia, Canada B3H 4R2 www.noveltechethics.ca www.impactethics.ca

Françoise Baylis is University Research Professor at Dalhousie University. She is a member of the Order of Canada and the Order of Nova Scotia, as well as a Fellow of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. In 2017 she was awarded the Canadian Bioethics Society Lifetime Achievement Award.

Baylis is a philosopher whose innovative work in bioethics, at the intersection of policy and practice, has stretched the very boundaries of the field. Her work challenges readers to think broadly and deeply about the direction of health, science and biotechnology. It aims to move the limits of mainstream bioethics and develop more effective ways to understand and tackle public policy challenges in Canada and abroad. She is the author of Altered Inheritance: CRISPR and the Ethics of Human Genome Editing and a member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing.

EDUCATION & CERTIFICATION

 PhD, Philosophy (specialization in Bioethics), University of Western Ontario 1989  MA, Philosophy, University of Western Ontario 1984  BA (First Class Honours), Political Science, McGill University 1983  Certificate of Bilingualism, Laurentian University 1981  Certificate of Law and Justice, Laurentian University 1981

HONOURS & AWARDS

 McDonald-Merrill-Ketcham Memorial Lectureship and Award for Excellence in 2020 Law and Medicine, Indiana University School of Medicine  Dalhousie University Research Professorship 2018-22 https://www.dal.ca/research/recognizingresearchexcellence/institutionalrecognition.html  Lloyd Fraser Award for Outstanding Senate Leadership, Dalhousie University 2018  Canadian Bioethics Society Lifetime Achievement Award 2017 https://www.bioethics.ca/lifetime-achievement-award  Biography included in “Beyond Rum and Salt Fish” A Souvenir Book commemorating Barbados’ 50th Anniversary of Independence as a Nation 2016  McNeil Medal for the Public Awareness of Science of the Royal Society of Canada 2016  Order of Nova Scotia 2016  Order of Canada 2016  Distinguished Academic Award, Canadian Association of University Teachers 2016  Canada Research Chair in Bioethics and Philosophy (Tier 1) 2011-18  Black in Canada (February 24,2011) 2011 Special Black History Month tribute, highlighting 28 of Canada’s top influencers & trailblazers  Fellow of the Royal Society of Canada 2007  Fellow of the Canadian Academy of Health Sciences 2007  The Ascension of Effort, Official Black History Month Poster featuring four successful Black 2006 Canadians (artist, Robert Small) dalnews.dal.ca/2006/02/17/blackhistory.html  Canadian Who’s Who 2004-

Françoise BAYLIS (23 March 2020) Page 1 of 53  Canada Research Chair in Bioethics and Philosophy (Tier 1) 2004-11  Dalhousie University Research Professorship 2003-08 (Interrupted in 2004 because of CRC)  Who’s Who in Black Canada, Black in Canada 2002- http://www.blackincanada.com/2010/08/27/francoise‐baylis/  Dalhousie Medical Research Foundation Award of Excellence in Medical Research 2001  Social Sciences and Humanities Research Council of Canada Doctoral Fellowship 1985-88  Ontario Graduate Scholarship (declined) 1985  Ontario Graduate Scholarship 1984  Entrance Scholarship, University of Western Ontario 1983-84  Special University Scholarship, University of Western Ontario 1983-84  Delta Upsilon and John W.F. Peacock Memorial Scholarship, McGill University 1983-84  James McGill Award, McGill University 1982-83  Programmes de moniteurs des langues officielles 1982  James McGill Entrance Award, McGill University 1981-82  Laurentian University Faculty Scholarship, Laurentian University (declined) 1981-82  Laurentian University Faculty Scholarship, Laurentian University 1980-81  Second Language Program Fellowship, Laurentian University 1980-81  RJ Askin Memorial Prize, Laurentian University 1980  ET Lute Memorial Prize, Laurentian University 1980  Laurentian Entrance Scholarship, Laurentian University 1979-80  Ruth E. Foley Memorial Scholarship, Laurentian University 1978-79  Ontario Scholar 1979

EMPLOYMENT

CURRENT ACADEMIC APPOINTMENTS Dalhousie University  University Research Professor

PREVIOUS APPOINTMENTS Dalhousie University  Professor and Canada Research Chair in Bioethics and Philosophy, Department of Bioethics, Faculty of Medicine, 2004-18 o cross appointment in the Department of Philosophy (since 1996) o cross appointment in the Department of Obstetrics and Gynaecology (since 2009)  Professor, Department of Bioethics, Faculty of Medicine, 2002-04  Acting Department Head, Department of Bioethics, Faculty of Medicine, 2000-01  Associate Professor, Department of Bioethics, Faculty of Medicine, 1999-2002  Associate Professor, Office of Bioethics Education and Research, Faculty of Medicine, 1996-1999

Arizona State University  Adjunct Professor, Centre for Biology and Society, 2010-19

Université de Montréal  Collaboratrice hors-Québec du Centre de Recherche en Éthique (CRÉ) 2014-19

University of Tennessee Knoxville  Assistant Professor, Department of Philosophy 1993-96

Hospital for Sick Children, Toronto  Bioethicist, Department of Bioethics 1991-93  Lecturer, Department of Pediatrics

Françoise BAYLIS (23 March 2020) Page 2 of 53  Lecturer, Department of Obstetrics and Gynaecology  Lecturer, Department of Rehabilitation Medicine

Westminster Institute for Ethics and Human Values, London, Ontario  Research Associate, 1989-90  Lecturer, Department of Obstetrics and Gynaecology, University of Western Ontario  Researcher, 1988-89  Graduate Research Assistant, 1987-88

VISITING FELLOWSHIPS  Visiting Researcher, Brocher Foundation, Geneva, Switzerland, October 2015  Visiting Scholar, Bioethics Centre, University of Otago, Dunedin, New Zealand, 2011  Visiting Professor, Centre for Biomedicine and Society, School of Social Science & Public Policy, King’s College London, 2009-12  Visiting Researcher, Brocher Foundation, Geneva, Switzerland, July 2008  Visiting Fellow, Centre de Recherche en Éthique de l’Université de Montréal (CRÉUM), 2003-04

OTHER ACADEMIC EMPLOYMENT  Academic Secretary, Medical Research Council, Working Group on Guidelines for Somatic Cell Gene Therapy, 1988  Instructor, Department of Philosophy, University of Western Ontario, 1984-85  Teaching Assistant, Department of Philosophy, University of Western Ontario, 1983-84

OTHER CLINICAL ETHICS EMPLOYMENT  Ethics Consultant, Board Ethics Committee, IWK-Grace Health Centre, Halifax, 1996-97  Clinical Associate in Medical Ethics, University of Tennessee Medical Centre Knoxville, 1993-96  Ethics Consultant, Department of Obstetrics and Gynaecology, University Hospital, London Ontario, Early Pre-Implantation Cell Screening (EPICS), and embryo freezing, 1991

INTERNATIONAL AND NATIONAL PROFESSIONAL SERVICE

INTERNATIONAL COMMITTEES  WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing, Geneva (Member), 2019-  Jury, Falling Walls Lab, Akademie der Künste, Berlin (Member), November 8, 2018  Board of Directors, International Association of Bioethics, (Member), 2017-2021  Jury, Falling Walls Lab, Akademie der Künste, Berlin (Member), November 8, 2017  Global Forum on Bioethics Research, Planning Committee ‘Ethical Issues of Research in Pregnancy’ Buenos Aires, 3-4 November 2016, (Member), 2016  US National Academy of Sciences, US National Academy of Medicine, Chinese Academy of Sciences and the UK's Royal Society Planning Committee ‘International Summit on Human Gene Editing’, Washington, 1-3 December 2015 http://www.nationalacademies.org/gene- editing/gene_167925 (Member), 2015  Comité d’experts du CRĒUM (Centre de Recherche en Ēthique de l’Université de Montréal), (Member), 2008-11  International Advisory Group for the REMEDiE project -- Regenerative Medicine in Europe: Emerging needs and challenges in a global context, (Member), 2008-11

GOVERNOR-IN-COUNCIL APPOINTMENTS  Assisted Human Reproduction Canada (AHRC), Board of Directors, 2006-10  Canadian Institutes of Health Research (CIHR), Governing Council, Dec. 2001- Dec. 04  Canadian Biotechnology Advisory Committee (CBAC), 1999-2001

Françoise BAYLIS (23 March 2020) Page 3 of 53 NATIONAL COMMITTEES  Canadian Bioethics Society, Awards Committee, 2020-21  Canadian Commission for UNESCO, Sectoral Commission, Natural, Social and Human Sciences, (Member), 2008-2017  Evidence for Democracy, Advisory Board, (Member), 2014-16  Canadian Centre for Ethics in Sport (CCES), Board of Directors, (Member), 2006-15  Canadian Institutes of Health Research (CIHR), Gender & Health Institute Advisory Board, (Member), 2009-14  Canadian Institutes of Health Research (CIHR), Institute Advisory Board Ethics Designates, 2009-11  Canadian Institutes of Health Research (CIHR), Priorities and Planning Committee, Institute of Genetics, Ethics, Legal and Social Issues, (ex officio, Member), 2002-04  Canadian Institutes of Health Research (CIHR), Standing Committee on Ethics, (Co-Chair), 2001-04  Canadian Institutes of Health Research (CIHR), Genetics Institute Advisory Board (Member), 2001  Genome Canada, Science and Industry Advisory Committee (SIAC), (Member), 2000-03  Canadian Institutes of Health Research (CIHR), Ad Hoc Working Group on Stem Cell Research, (Member), 2000-01  National Reference Group on Post-Exposure Prophylaxis, Health Canada, (Member), 2000-01  Canadian Institutes of Health Research (CIHR) Interim Governing Council Sub-Committee on Ethics, (Member of Advisory Group),1999  Social Sciences and Humanities Research Council (SSHRC)/ Canadian Institutes of Health Research (CIHR) Health Activities, Advisory Committee, (Member) 1999  Royal College Physicians and Surgeons of Canada (RCPSC), Biomedical Ethics Committee, (Member), 1999-2001  National Council on Ethics in Human Research (NCEHR), Council, (Member), 1998-2000  National Council on Ethics in Human Research (NCEHR), Ethics of Research Design Committee, (Member), 1999-2000  National Council on Ethics in Human Research (NCEHR), Consent Committee, (Member), 1993-99  Society of Obstetricians and Gynaecologists of Canada (SOGC), Ethics Committee, (Member), 1994- 97

NATIONAL COMMITTEES: CO-AUTHOR OF FINAL REPORTS  Ad Hoc Working Group on Stem Cell Research (2002). Human pluripotent stem cell research. Recommendations for CIHR-funded research. Canadian Institutes of Health Research. http://www.irsc.gc.ca/e/1489.html  Sherwin, S., Baylis, F., Bernstein A., Caulfield, T., Dickens, B., Downie, J. et al. (1999). Integrating bioethics and health law into the Canadian Institutes of Health Research  American Society for Bioethics and Humanities (1998). Core competencies for health care ethics consultation. Glenview, IL: ASBH.  Rodgers, S., Baylis, F., Lippman, A., MacMillan, J., Parish, B., Nisker, J. (Chair) (1997). SOGC Clinical Practice Guidelines. Policy statement: Involuntary intervention in the lives of pregnant women. Journal of the Society of Obstetricians and Gynaecologists of Canada, 19, 1200-1203.  Rodgers, S., Baylis, F., Lippman, A., MacMillan, J., Parish, B., Nisker, J. (Chair) (1997). SOGC Clinical Practice Guidelines. Policy statement: Preconception arrangements. Journal of the Society of Obstetricians and Gynaecologists of Canada, 19, 393-399.  National Council on Ethics in Human Research (1996). Facilitating ethical research: Promoting informed choice [Discussion document]. NCEHR Communiqué CNERH, (Suppl.) 7(2), i-28. http://www.ncehr-cnerh.org/english/consent/consente.htm  National Council on Bioethics in Human Research (1990). Ethical aspects of pharmaceutically-based clinical investigation. Annals of the Royal College of Physicians and Surgeons of Canada, 23, 436- 438.

NATIONAL COMMITTEE MEETINGS: CONSULTANT  Law Commission of Canada. Study Panel. Does age matter? Law and relationships between generations [2004 Discussion paper], February 2006.

Françoise BAYLIS (23 March 2020) Page 4 of 53  HIV/AIDS Policy Co-ordination Division, Health Canada, September 1998.  Women's Health Bureau, Health Canada, January 1998.  Tri-council working group. Code of ethical conduct for research involving humans. Ottawa: MRC, NSERC, SSHRC, February 1997.  Medical Research Council, Advisory Committee on Women in Clinical Trials, May 1995.

SCHOLARLY RESEARCH ACTIVITIES SUMMARY Books & Journal Special Issues 23 Refereed Publications 93 Book Chapters & Encyclopedia Contributions 47 Non‐Refereed publications, correspondence, blogs, 182 print media & reviews Presentations 372

Grants Received 78 Principal Investigator $ 7,071,734.11 Co‐Investigator $ 25,922,938.75 Collaborator $ 3,732,534.14 Research Contracts Received 12

RESEARCH AREAS

 Ethics, bioethics, clinical ethics  Women’s health  Assisted human reproduction  Genetic technologies  Human enhancement  Health law and ethics issues  Health policy  Research ethics  Public health ethics

PUBLICATIONS

Unless otherwise indicated, authors are listed alphabetically and the contribution of each co-author or co- editor should be presumed to be equal. When the contribution is not equal and/or the listing is not alphabetical, the nature of my contribution is specified.

ORCID ID http://orcid.org/0000-0003-2961-5802

SSRN ID http://ssrn.com/author=369575

AMAZON ID http://www.amazon.com/-/e/B00JA075L8

THESIS

Françoise BAYLIS (23 March 2020) Page 5 of 53 Baylis, F. (1989). The ethics of ex utero research on spare IVF human embryos. PhD (Department of Philosophy) University of Western Ontario, London, Ontario.

BOOKS (19) 1. Baylis, F. (September 2019). Altered Inheritance: CRISPR and the ethics of human genome editing. Harvard, Harvard University Press. https://www.youtube.com/watch?v=fGvocYptluo 2. Baylis, F., & Dreger, A. (Eds). (2018). Bioethics in action. Cambridge, Cambridge University Press. Reprinted in paperback 2019. 3. Baylis, F., & Ballantyne, A. (Eds). (2016) Clinical research involving pregnant women. Cham, Switzerland: Springer. 4. Baylis, F., & McLeod, C. (Eds.). (2014) Family-making: Contemporary ethical challenges Oxford: Oxford University Press. Reprinted in paperback 2017. 5. Baylis, F., Hoffmaster, B., Sherwin S., & Borgerson K. (Eds.). (2012) Health care ethics in Canada (3rd ed.) Toronto: Nelson. 6. Nisker, J., Baylis, F., Karpin I., McLeod C., & Mykitiuk R. (Eds.). (2010) The ‘healthy’ embryo: Social, biomedical, legal and philosophical perspectives Cambridge: Cambridge University Press. 7. Baylis, F., Downie, J., Hoffmaster, B., & Sherwin, S. (Eds.). (2004). Health care ethics in Canada (2nd ed.). Toronto: Thomson Nelson. 8. Freedman, B. (2000). (F. Baylis, Ed.). The roles and responsibilities of the ethic consultant: A retrospective analysis of cases. Hagerstown, Md: University Publishing Group. 9. Baylis, F., Ireland, A., Kaufman, D., & Weijer, C. (2000). Protecting human research subjects: Case- based learning for Canadian research ethics boards and researchers. Ottawa: National Council on Ethics in Human Research. 10. Baylis, F., Downie, J., & Dewhirst, K. (Eds.). (1999). Codes of ethics: Ethics codes, standards and guidelines for professionals working in a health care setting in Canada (2nd ed.). Toronto: Department of Bioethics, The Hospital for Sick Children. 11. Sherwin, S., Baylis, F., Bell, M., DeKoninck, M., Downie, J., Lippman, A. et al. (1998). The politics of women's health: Exploring agency and autonomy. Philadelphia: Temple University Press. 12. Baylis, F., Downie, J., Freedman, B., Hoffmaster, B., & Sherwin, S. (Eds.). (1995). Health care ethics in Canada (1st ed.). Toronto: Harcourt Brace and W.B. Saunders. 13. Baylis, F., Eckenwiler, L.A., & Kunicki, L. (Eds.). (1994). Institutional policy in paediatric practice: Documenting Canadian experience. Toronto: Department of Bioethics, The Hospital for Sick Children. 14. Baylis, F. (Ed.). (1994). The health care ethics consultant. Totowa, N.J: Humana Press. 15. Baylis, F., & McBurney, C. (Eds.). (1993). In the case of children: Paediatric ethics in a Canadian context. Toronto: Department of Bioethics, The Hospital for Sick Children. 16. Baylis, F. & Downie, J. (Eds.). (1992). Codes of ethics: Ethics codes, standards and guidelines for professionals working in a health care setting in Canada (1st ed.). Toronto: Department of Bioethics, The Hospital for Sick Children. 17. Baylis, F., & Downie, J. (Eds.). (1990). Medical ethics for postgraduate medical students: Symposium' 90 proceedings. London, Ont.: Westminster Institute for Ethics and Human Values. 18. Baylis, F., & Downie, J. (1990). Undergraduate medical ethics education: A survey of Canadian medical schools. London, Ont.: Westminster Institute for Ethics and Human Values. 19. Baylis, F., & Downie, J. (Eds.). (1990). Medical ethics for undergraduate medical: Symposium '89 proceedings. London, Ont.: Westminster Institute for Ethics and Human Values.

Françoise BAYLIS (23 March 2020) Page 6 of 53

JOURNAL SPECIAL ISSUES (4) 1. Baylis, F. & Downie J. (Guest Eds.) (2014) Transnational reproductive travel. International Journal of Feminist Approaches to Bioethics 7(2). 2. Baylis, F. & Downie, J (Guest Eds.) (2009) Neuroethics. Bioethics 23(6). 3. Reid, L., Johnston, J., & Baylis, F. (Guest Eds.). (2006). Ethics and stem cell research: Shifting the discourse. Journal of Bioethical Inquiry, 3(1/2). 4. Baylis, F. (Guest Ed.) (1993). Health care ethics consultation in Canada. Healthcare Ethics Committee Forum, 5(3).

REFEREED PUBLICATIONS (93) 1. Andorno, R., Baylis, F., Darnovsky, M., Dickenson, D., Haker, H., Hasson, K., (2020). Geneva statement on heritable human genome editing: The need for course correction. Trends in Biotechnology, 38(4), 351-354. 2. Saha, K., Hurlbut, J.B., Jasanoff, S., Ahmed, A., Appiah, A., Bartholet, E., Baylis, F. et al. (2018). Building capacity for a global genome-editing observatory: Institutional design. Trends in Biotechnology. 36(8), 741-743. DOI: 10.1016/j.tibtech.2018.04.008. 3. Hurlbut, J.B., Jasanoff, S., Saha, K., Ahmed, A., Appiah, A., Bartholet, E., Baylis, F. et al. (2018). Building capacity for a global genome-editing observatory: Conceptual challenges. Trends in Biotechnology. 36(7), 639-641. DOI: 10.1016/j.tibtech.2018.04.009. 4. Baylis, F. (2018). ‘No’ to lesbian motherhood using human nuclear genome transfer. Journal of Medical Ethics. 44(12), 865-867. DOI:10.1136/medethics-2018-104860. 5. Baylis, F. (2018). COUNTERPOINT: The potential harms of human gene editing using CRISPR- Cas9. Clinical Chemistry. 64(3), 489-491. DOI: 10.1373/clinchem.2017.278317. 6. Baylis, F., & McLeod, M. (2018). First-in-human phase 1 CRISPR gene editing cancer trials: Are we ready? Current Gene Therapy 17(4), 309-319. DOI: 10.2174/1566523217666171121165935. 7. Downie, J., & Baylis, F. (2017). A test for freedom of conscience under the Canadian Charter of Rights and Freedoms: Regulating and litigating conscientious refusals in health care. McGill Journal of Law and Health, 11(1), 1-30 https://mjlh.mcgill.ca/issues/volume-111/a-test-for-freedom-of- conscience-under-the-canadian-charter-of-rights-and-freedoms-regulating-and-litigating- conscientious-refusals-in-health-care/ 8. Baylis, F., Cattapan, A., & Snow, D. (2017). Editorial misconduct. Public Affairs Quarterly 31(2), 143- 155. 9. Baylis, F. (2017). Still Gloria: Personal identity and dementia. International Journal of Feminist Approaches to Bioethics 10(1), 210-224. 10. Baylis, F. (2017). Human nuclear genome transfer (so-called mitochondrial replacement): Clearing the underbrush. Bioethics 31(1), 7-19. DOI:10.1111/bioe.12309. 11. Vasiliou, S.K., Diamandis, E.P., Church, G.M, Greely, H.T., Baylis, F., Thompson, C., & Schmitt- Ulms, G. (2016). CRISPR-Cas9 system: Opportunities and concerns. Clinical Chemistry 62(10), 1304-11. DOI: 10.1373/clinchem.2016.263186. 12. Cattapan, A., & Baylis F. (2016). Frozen in perpetuity: ‘Abandoned embryos’ in Canada. Reproductive Biomedicine & Society Online, 1(2), 104-112 DOI: 10.1016/j.rbms.2016.04.002. http://dx.doi.org/10.1016/j.rbms.2016.04.002. 13. Krahn, T.M., and Baylis, F. (2016). A review of consent documents from Canadian IVF clinics,1991 to 2014. Journal of Obstetrics and Gynaecology Canada, 38(5), 470-482. DOI:

Françoise BAYLIS (23 March 2020) Page 7 of 53 10.1016/j/jogc.2016.02.008. http://www.jogc.com/issue/S1701-2163(16)X0006-0; http://www.ncbi.nlm.nih.gov/pubmed/27261224 14. Baylis, F., and Widdows, H. (2015). Human embryos and eggs: from long-term storage to biobanking. Monash Bioethics Review, 33(4), 340-359 DOI: 10.1007/s40592-015-0045-8. http://link.springer.com/article/10.1007/s40592-015-0045-8 15. Snow, D., Baylis, F., and Downie, J. (2015). Why the government of Canada won’t regulate assisted human reproduction: A modern mystery. McGill Journal of Law and Health, 9 (1), 1-15. https://mjlh.mcgill.ca/issues/volume-9-issue-1-91-2015-16/why-the-government-of-canada-wont- regulate-assisted-human-reproduction-a-modern-mystery/ 16. Baylis, F. (2015). A relational view of conscience and physician conscientious action. International Journal of Feminist Approaches to Bioethics 8(1), 18-36. 17. Petropanagos, A., Cattapan, A., Baylis, F., and Leader A. (2015). Social egg freezing: risk, benefit and social considerations. Canadian Medical Association Journal 187(9): 666-669. Epub 2015 April 13. 18. Baylis, F. (2015). Left out in the cold: Arguments against non-medical oocyte cryopreservation. Journal of Obstetrics and Gynaecology Canada 37(1), 64-67. 19. Baylis, F., Downie, J. (2014). Achieving national altruistic self-sufficiency in human eggs for third- party reproduction in Canada. International Journal of Feminist Approaches to Bioethics 7(2), 164- 184. 20. Baylis, F., Downie, J. & Snow, D. (2014). Fake it till you make it: Policymaking and assisted human reproduction in Canada. Journal of Obstetrics and Gynaecology Canada 36(6), 510-512. 21. Downie, J. & Baylis, F. (2013). The tale of Assisted Human Reproduction Canada: A tragedy in five acts. Canadian Journal of Women and the Law 25(2), 183-201. DOI: 10.3138/cjwl.25.2.183. 22. Baylis, F. (2013). “I am who I am”: On the perceived threats to personal identity from deep brain stimulation. Neuroethics 6, 513-526. EPub 2011 September 14. DOI: 10.1007/s12152-011-9137-1 http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s12152-011-9137-1 23. Downie, J. & Baylis, F. (2013). Transnational trade in human eggs: Law, policy, and (in)action in Canada. Journal of Law, Medicine and Ethics 41(1), 224-239. DOI: 10.1111/jlme.12015. 24. Baylis, F. & Halperin, S. (2012). Research involving pregnant women: Trials and tribulations. Clinical Investigation 2(2), 139-146. DOI: 10.4155/CLI.11.183. http://www.openaccessjournals.com/articles/research-involving-pregnant-women-trials-and- tribulations.pdf 25. Baylis, F. & Downie, J. (2012). Unfinished business: Ongoing ethical exceptionalism in the oversight of human pluripotent stem cell research in Canada. Accountability in Research: Policies and Quality Assurance 19(1), 13-26. DOI: 10.1080/08989621.2012.638595. 26. Steenbeek, A., MacDonald, N., Downie, J. Appleton, M. & Baylis, F. (2012). Ill-informed consent? A content analysis of physical risk disclosure in Canadian school-based HPV vaccine programs Public Health Nursing 29(1), 71-79. DOI: 10.1111/j.1525-1446.2011.00974.x [ePub 2011 Oct 17]. 27. Bretzner, F., Gilbert, F., Baylis, F. & Brownstone, R. (2011). Target populations for first-in-human embryonic stem cell research in spinal cord injury Cell Stem Cell 8(5), 468-475. DOI 10.1016/j.stem.2011.04.012. 28. Kaposy, C. & Baylis, F. (2010). Ethical, evidence-based guidelines for contraceptive use in research. IRB: Ethics & Human Research 32(5), 1-9. 29. Crozier, G. & Baylis, F. (2010). The ethical physician encounters international medical travel. Journal of Medical Ethics 36(5), 297-301. DOI:10.1136/ard.2009.032789. Reprinted in: (2012) F. Baylis, B. Hoffmaster, S. Sherwin and K. Borgerson (Eds), Health Care Ethics in Canada (pp. 147-155). Toronto: Nelson Education.

Françoise BAYLIS (23 March 2020) Page 8 of 53 30. Baylis, F. & Kaposy, C. (2010). Wanted: Inclusive guidelines for research involving pregnant women. Journal of Obstetrics and Gynaecology Canada 32(5), 473-476. 31. Kenny, N., Sherwin, S., & Baylis F. (2010). Re-visioning public health ethics: A relational perspective. Canadian Journal of Public Health 101(1), 9-11. Reprinted in: (2012) F. Baylis, B. Hoffmaster, S. Sherwin and K. Borgerson (Eds), Health Care Ethics in Canada (pp. 160-164). Toronto: Nelson Education. 32. Baylis, F. & Krahn T. (2009).The trouble with embryos. Science Studies 22(2), 31-54. 33. Baylis, F. (2009). For love or money: The saga of Korean women who provided eggs for embryonic stem cell research. Theoretical Medicine and Bioethics 30(5), 385-396. DOI: 10.1007/s11017-009- 9118-0 34. Baylis, F. (2009). “Babies with some animal DNA in them”: A woman’s choice? International Journal of Feminist Approaches to Bioethics 2(2), 75-96. 35. Baylis, F. & Herder M. (2009). Policy design for human embryo research in Canada: An analysis. Part 2 of 2 Journal of Bioethical Inquiry 6(3), 351-365. DOI: 10.1007/s11673-009-9145- 36. Baylis, F. (2009). The HFEA public consultation process on hybrids and chimeras: informed, effective and meaningful? Kennedy Institute of Ethics Journal 19(1), 41-62. DOI: 10.1353/ken.0.0273 37. Baylis, F. & Herder M. (2009). Policy design for human embryo research in Canada: A history. Part 1 of 2 Journal of Bioethical Inquiry 6(1), 109-122. DOI: 10.1007/s11673-009-9135-8 38. Fenton, A., Meynell, L. & Baylis, F. (2009). Ethical challenges and interpretive difficulties with non- clinical applications of pediatric fMRI. American Journal of Bioethics 9(1), 3-13. (33% contribution) DOI: 10.1080/15265160802617829 39. Baylis, F. (2008). Animal eggs for stem cell research: A path not worth taking. American Journal of Bioethics 8(12), 18-32. DOI: 10.1080/15265160802559161 Adapted and reprinted as: Humanesque embryos. (2010) J., Nisker, F., Baylis, I., Karpin, C., McLeod, & R., Mykitiuk (Eds.), The healthy embryo: Social, biomedical, legal and philosophical perspectives (pp. 84-96). Cambridge: Cambridge University Press. 40. Baylis, F., Kenny, S., & Sherwin, S. (2008). A relational account of public health ethics. Public Health Ethics 1(3), 196-209. DOI:10.1093/phe/phn025 41. Viirre, E., Baylis, F., & Downie, J. (2007). Promises and perils of cognitive performance tools: A dialogue. Technology 11, Supplement 1, 9-25. (33% contribution) DOI: 10.3727/107292408786938853 Reprinted in: (2012) J., Giordano (Ed.), Neurotechnology: Premises, Potential, and Problems (pp 125-141).Taylor and Francis LLC. 42. Baylis, F. & McLeod, C. (2007). The stem cell debate continues: The buying and selling of eggs for research. Journal of Medical Ethics 33, 726-731. DOI:10.1136/jme.2007.022129 43. McLeod, C., & Baylis, F. (2007). Donating fresh versus frozen embryos to stem cell research: In whose interests? Bioethics, 21, 465-477. DOI: 10.1111/j.1467-8519.2007.00592.x (50% contribution) Reprinted in: (2010) J., Nisker, F., Baylis, I., Karpin, C., McLeod & R. Mykitiuk R. (Eds.), The healthy embryo: Social, biomedical, legal and philosophical perspectives (pp. 171-186). Cambridge: Cambridge University Press. 44. Giacomini, M., Baylis, F., & Robert, J. S. (2007). Banking on it: Public policy and the ethics of stem cell research and development. Social Science & Medicine, 65, 1490-1500. (33% contribution) DOI:10.1016/j.socscimed.2007.05.021 45. Baylis, F. & McInnes, C. (2007). Women at risk: Embryonic and fetal stem cell research in Canada. McGill Journal of Law and Health, 1, 53-67. https://mjlhmcgill.files.wordpress.com/2017/07/baylis- mcinnes.pdf 46. Baylis, F. & Fenton, A. (2007). Chimera research and stem cell therapies for human neurodegenerative disorders. Cambridge Quarterly of Healthcare Ethics, 16, 195-208. DOI:10.1017/S0963180107070211

Françoise BAYLIS (23 March 2020) Page 9 of 53 47. Baylis, F., & Robert, J. S. (2006). Human embryonic stem cell research: An argument for national research review. Accountability in Research: Policies and Quality Assurance, 13(3) , 207-224. DOI: 10.1080/03605300600848136 48. Kimmelman, J., Baylis, F., & Glass, K. C. (2006). Stem cell trials: Lessons from gene transfer research. Hastings Center Report, 36, 23-26. (40% contribution) 49. McLeod, C., & Baylis, F. (2006). Feminists on the inalienability of human embryos. Hypatia, 21, 1-14. (45% contribution). Reprinted in: (2012) C., Weijer, A. Skelton & S Brennan (Eds.), Bioethics in Canada (pp xx).Oxford University Press. 50. Nisker, J., Baylis, F., & McLeod, C. (2006). Choice in fertility preservation in girls and adolescent women with cancer. Cancer, 107 (S7), 1686-1689. (35% contribution) DOI 10.1002/cncr.22106 51. Baylis, F., & Ram, N. (2005). Eligibility of cryopreserved human embryos for stem cell research in Canada. Journal of Obstetrics and Gynaecology Canada, 27, 949-955. 52. Downie, J., Llewellyn, J., & Baylis, F. (2005). A constitutional defence of the federal ban on human cloning for research purposes. Queen's Law Journal, 31, 353-384. (25% contribution) 53. Robert, J. S., & Baylis, F. (2005). Stem cell politics: The NAS prohibitions pack more bark than bite. Hastings Center Report, 35, 15-16. (50% contribution) 54. Baylis, F., & Robert, J. S. (2004). The inevitability of genetic enhancement technologies. Bioethics, 18, 1-26. Reprinted in: (2004). F. Baylis, J. Downie, B. Hoffmaster, & S. Sherwin (Eds.), Health Care Ethics in Canada (2nd ed., pp. 448-460). Toronto: Thomson Nelson; and (2009) J. Fisher (Ed) Biomedical Ethics: A Canadian Focus (pp.328-337). Don Mills: Oxford University Press; and (2012) F. Baylis, B. Hoffmaster, S. Sherwin and K. Borgerson (Eds), Health Care Ethics in Canada (pp. 504-516). Toronto: Nelson Education. 55. Baylis, F. (2004). The Olivieri debacle: Where were the heroes of bioethics? A reply to Mary Rowell. Journal of Medical Ethics, 30, 51-52. DOI: 10.1136/jme.2003.007724 56. Baylis, F. (2004). The Olivieri debacle: Where were the heroes of bioethics? Journal of Medical Ethics, 30, 44-49. DOI: 10.1136/jme.2003.005330 57. Johnston, J., & Baylis, F. (2004). Gene therapy: Two steps forward, one step back. Canadian Medical Association Journal, 170, 1785-1786. (45% contribution) DOI: 10.1503/cmaj.1031262. 58. Johnston, J., & Baylis, F. (2004). What happened to gene therapy? A review of recent events. Clinical Researcher, 4, 11-15. (45% contribution) 59. Baylis, F. (2003). Black as me: Narrative identity. Developing World Bioethics, 3, 142-150. DOI: 10.1046/j.1471-8731.2003.00070.x Translated and reprinted: (2006) “Noire” comme moi ou de l’identité narrative, In: M-H., Parizeau & S., Kash (Eds.), Néoracisme et dérives génétiques (pp. 247- 257). Québec: Les Presses de l’Université Laval. 60. Baylis, F., Beagan, B., Johnston, J., & Ram, N. (2003). Cryopreserved human embryos in Canada and their availability for research. Journal of Obstetrics and Gynaecology Canada, 25, 1026-1031. 61. Giacomini M, & Baylis, F. (2003). Excluding women from medical research: Reasons and rejoinders. Clinical Researcher, 3, 12-15. (45% contribution) 62. Robert, J. S., & Baylis, F. (2003). Crossing species boundaries. American Journal of Bioethics, 3(3), 1-13 (50% contribution). Reprinted in: (2005) T.A. Shannon (Ed), Genetics: Science, Ethics and Public Policy: A Reader (pp.11-32). Lanham, MD: Rowman & Littlefield; and (2014) R.L. Sandler (Ed), Ethics and Emerging Technologies (pp. 139-154). N.Y.: Palgrave MacMillan. 63. Sherwin, S., & Baylis, F. (2003). The feminist health care ethics consultant as architect and advocate. Public Affairs Quarterly, 17, 141-158. (40% contribution) 64. Fernandez, C. V., Gordon, K., Van den, H. M., Taweel, S., & Baylis, F. (2003). Knowledge and attitudes of pregnant women with regard to collection, testing and banking of cord blood stem cells. Canadian Medical Association Journal, 168, 695-698. (5% contribution)

Françoise BAYLIS (23 March 2020) Page 10 of 53 65. Baylis, F. (2002). Human embryonic stem cell lines: The ethics of derivation. Journal of Obstetrics and Gynaecology Canada, 24, 159-163. 66. Baylis, F. (2002). Human cloning: Three mistakes and an alternative. Journal of Medicine and Philosophy, 27, 319-337. DOI: 10.1076/jmep.27.3.319.2984 Reprinted in: (2005). E. H. Kluge (Ed.), Readings in biomedical ethics: A Canadian focus 3rd Edition (pp.488-501).Toronto: Prentice-Hall; and (2004). F. Baylis, J. Downie, B. Hoffmaster, & S. Sherwin (Eds.), Health Care Ethics in Canada (pp.437-448). Toronto: Thomson Nelson; and (2012) F. Baylis, B. Hoffmaster, S. Sherwin and K. Borgerson (Eds), Health Care Ethics in Canada (pp. 492-503). Toronto: Nelson Education. 67. Gibson, E., Baylis, F., & Lewis, S. (2002). Dances with the pharmaceutical industry. Canadian Medical Association Journal, 166, 448-450. (35% contribution) 68. Baylis, F. (2001). The Canadian stem cell debate: Stuck in the '80s. Journal of the Society of Obstetricians and Gynaecologists of Canada, 23, 248-252. 69. Baylis, F., & Downie, J. (2001). Professional recommendations: Disclosing facts and values. Journal of Medical Ethics, 27, 20-24. DOI: 10.1136/jme.27.1.20 70. Lewis, S., Baird, P., Evans, R. G., Ghali, W. A., Wright, C. J., Gibson, E. & Baylis, F. (2001). Dancing with the porcupine: Rules for governing the university-industry relationship. Canadian Medical Association Journal, 165, 783-785. (5% contribution) Reprinted in: (2005). E. H. Kluge (Ed.), Readings in biomedical ethics: A Canadian focus (pp. 258-262). Toronto: Prentice-Hall; and (2004). F. Baylis, J. Downie, B. Hoffmaster, & S. Sherwin (Eds.), Health Care Ethics in Canada (pp. 340-344). Toronto: Thomson Nelson; and (2012) F. Baylis, B. Hoffmaster, S. Sherwin and K. Borgerson (Eds), Health Care Ethics in Canada (pp. 351-355). Toronto: Nelson Education. 71. Baylis, F. (2000). Heroes in bioethics. Hastings Center Report, 30, 34-39. Reprinted in: (2000). B. Freedman, [F. Baylis (Ed.], The roles and responsibilities of the ethics consultant: A retrospective analysis of cases (pp.143-152). Hagerstown, Md: University Publishing Group. 72. Baylis, F. (2000). Rebuttal: Expert ethics testimony. Journal of Law Medicine and Ethics, 28, 240- 242. 73. Baylis, F. (2000). Expert testimony by persons trained in ethical reasoning: The case of Andrew Sawatzky. Journal of Law Medicine and Ethics, 28, 224-231. 74. Baylis, F. (2000). Our cells/ourselves: Creating human embryos for stem cell research. Women's Health Issues, 10, 140-145. DOI:10.1016/S1049-3867(00)00042-6 75. Baylis, F. (1999). IRBs: Protecting the well-being of subject-participants with mental disorders that may affect decisionmaking capacity. Accountability in Research, 7, 183-199. Reprinted in: (2002). A. Shamoo (Ed.), Research and decisional capacity: Responding to the National Bioethics Advisory Commission (pp. 117-133). New York: Taylor & Francis. 76. Baylis, F. (1999). Health care ethics consultation: 'Training in virtue'. Human Studies, 22, 25-41. DOI: 10.1023/A:1005456601398 Reprinted in: (1999). R. M. Zaner (Ed.), Performance, talk, reflection: What is going on in clinical ethics consultation (pp. 25-41). Dordrecht: Kluwer Academic Publishers. 77. Baylis, F., Downie, J., & Kenny, N. (1999). Children and decisionmaking in health research. IRB: A review of Human Subjects Research, 21, 5-10. Reprinted in: (1999). Health Law Review, 8(2): 3-9. 78. Caniano, D. A., & Baylis, F. (1999). Ethical considerations in prenatal surgical consultation. Pediatric Surgery International, 15, 303-309. (50% contribution) DOI: 10.1007/s003830050588 79. Kenny, N., Weijer, C., & Baylis, F. (1999). Voting ourselves rights: A critique of the Canadian Medical Association charter for physicians. Canadian Medical Association Journal. 161, 399-400. (25% contribution) 80. Baylis, F., & Ginn, D. (1998). Expanding access to PEP: Ethical and legal issues. AIDS and Public Policy Journal, 13, 140-167. Reprinted and distributed by: (1999). Canadian HIV/AIDS

Françoise BAYLIS (23 March 2020) Page 11 of 53 Clearinghouse (pp.1-26); also, excerpt reprinted as: (1999). Post-exposure prophylaxis. Canadian HIV/AIDS Policy & Law Newsletter, 4(4):29-38. 81. Baylis, F. (1998). Dissenting with the dissent: Winnipeg Child and Family Services (Northwest Area) v. G. (D.F.). Alberta Law Review, 36, 785-798. 82. Baylis, F. (1997). Errors in medicine: Nurturing truthfulness. Journal of Clinical Ethics, 8, 336-340. Reprinted in: (2012) J. Arras, A. London, & B. Steinbock (Eds.), Ethical issues in modern medicine (8th ed.). London: McGraw Hill; and (2008) B. Steinbock, A. London & J. Arras (Eds.), Ethical issues in modern medicine (7th ed., pp.97-100). London: McGraw-Hill; and (2002). B. Steinbock, J. Arras, & A. London (Eds.), Ethical issues in modern medicine (6th ed., pp.107-111). London: McGraw-Hill. 83. Flagler, E., Baylis, F., & Rodgers, S. (1997). Bioethics for clinicians: 12. Ethical dilemmas that arise in the care of pregnant women: Rethinking "maternal-fetal conflicts". Canadian Medical Association Journal, 156, 1729-1732. (40% contribution) Reprinted in: (1999). P. Singer (Ed.), Bioethics at the bedside: A clinician’s guide (pp. 71-78). Ottawa: Canadian Medical Association. 84. Kleinman, I., Baylis, F., Rodgers, S., & Singer, P. (1997). Bioethics for clinicians: 8. Confidentiality. Canadian Medical Association Journal, 156, 521-524. (40% contribution) Reprinted in: (1999) P. Singer (Ed.), Bioethics at the bedside: A clinician’s guide (pp. 55-62). Ottawa: Canadian Medical Association. 85. Baylis, F. (1996). Women and health research: Working for change. Journal of Clinical Ethics, 7, 229-242. 86. Baylis, F., DesBrisay J, Freedman B, Lowenstein L, & Sherwin, S. (1994). A reply to Giles R Scofield. Healthcare Ethics Committee Forum, 6, 371-376. DOI: 10.1007/BF01439313 87. Baylis, F. (1993). Therapist-patient sexual contact: A non consensual, inherently harmful activity. Canadian Journal of Psychiatry, 38, 502-506. Reprinted in: (1997). R. Edwards (Ed.), Ethics of psychiatry (2nd ed., pp. 294-304). Buffalo, N.Y.: Prometheus Books. 88. Baylis, F., & Downie, J. (1993). An ethical and criminal law framework for research involving children in Canada. Health Law Journal, 1, 39-64. 89. Baylis, F., & Downie, J. (1991). Ethics education for Canadian medical students. Academic Medicine, 66, 413-414. 90. Baylis, F. (1991). Ethics consultation: The Hospital for Sick Children initiative [Toronto, Ontario]. Healthcare Ethics Committee Forum, 3, 285-292. 91. Baylis, F. (1990). The ethics of ex utero research on spare 'non-viable' IVF human embryos. Bioethics, 4, 311-329. DOI: 10.1111/j.1467-8519.1990.tb00094.x 92. Baylis, F. (1989). Resuscitation of the terminally ill: A response to Buckman and Senn. Canadian Medical Association Journal, 141, 1043-1044. 93. Freedman, B., & Baylis, F. (1987). Purpose and function in government-funded health coverage. Journal of Health Politics, Policy and Law, 12, 97-112. DOI: 10.1215/03616878-12-1-97 (40% contribution) Reprinted in: (1993) (1999) and (2005; pp. 63-75). E. H. Kluge (Ed.), Readings in biomedical ethics: A Canadian focus. Toronto: Prentice-Hall; and (1995). F. Baylis, J. Downie, B. Freedman, B. Hoffmaster, & S. Sherwin (Eds.), Health care ethics in Canada (pp. 130-145). Toronto: Harcourt Brace and W.B. Saunders; and (2000). E. Boetzkes, & W. Waluchow (Eds.), Readings in health care ethics. Peterborough, Ont.: Broadview Press.

BOOK CHAPTERS (37) 1. Baylis, F., & Cattapan A. (2018). Personalised medicine and the politics of human nuclear genome transfer. In: B. van Beers, S. Sterckx, & D. Dickenson (Eds), Personalized medicine, individual choice and the common good, (17-36). Cambridge: Cambridge University Press. DOI:10.1017/9781108590600.002.

Françoise BAYLIS (23 March 2020) Page 12 of 53 2. Dreger, A., & Baylis, F. (2018). More than Words. In: F. Baylis, & A. Dreger (Eds), Bioethics in action, (1-8). Cambridge: Cambridge University Press. 3. Baylis, F., & Downie, J. (2018). Where there’s smoke, there’s Pfizer. In: F. Baylis, & A. Dreger (Eds), Bioethics in action, (9-31). Cambridge: Cambridge University Press. 4. Baylis, F. (2017). The regulation of assisted human reproductive technologies and related research: A public health, safety and morality argument. In: T. Lemmens, A.F. Martin, C, Milne, and I.B. Lee (Eds), Regulating creation: The law, ethics and policy of assisted human reproduction, (490-528). Toronto: University of Toronto Press. 5. Baylis F. (2016). Ethical commentary – Abortion and Physician Conscientious Action. In S.W. Smith, J. Coggon, C. Hobson, R. Huxtable, S. McGuinness, J. Miola, & M. Neal (Eds), Ethical judgments: Re-Writing medical law, (164-171) Oxford: Hart Publishing. 6. Baylis, F. & Ballantyne, A. (2016). Missed trials, future opportunities. In F. Baylis, & A. Ballantyne (Eds), Clinical research involving pregnant women, (1-12) Cham, Switzerland: Springer. 7. Baylis, F. & MacQuarrie, R. (2016). Why physicians and women should want pregnant women included in clinical trials. In F. Baylis, & A. Ballantyne (Eds), Clinical research involving pregnant women, (14-29) Cham, Switzerland: Springer. 8. Baylis, F. & Herder, M. (2016). Policy design for human embryo research in Canada: 1989-2015. In. S. Dodds & R. Ankeny (Eds), Big picture bioethics: Developing democratic policy in contested domains, (73-105) Cham, Switzerland: Springer. 9. Baylis, F. (2015). Human embryos for reproduction and research. In J. Arras, E. Fenton & R. Kukla (Eds.), The routledge companion to bioethics, (357-369) New York, N.Y.: Routledge. 10. Baylis, F. (2015). Neuroethics and Identity. In: J. Clausen, N. Levy (Eds.), Handbook of neuroethics, (pp. 367-372). Springer Science+Business Media Dordrecht DOI 10.1007/978-94-007-4707-4_9. 11. Baylis, F. (2014). Transnational commercial contract pregnancy in India. In Baylis, F. & McLeod, C. (Eds.), Family-making: Contemporary ethical challenges (265-286). London: Oxford University Press. Reprinted in paperback 2017. 12. Kaposy, C., & Baylis, F. (2012). Ethical issues in pregnancy and reproduction. In J. Storch, P. Rodney & R. Starzomski (Eds.), Toward a moral horizon: Nursing ethics for leadership and practice, 2nd Edition (pp.473-490). Toronto: Pearson Education Canada. 13. Baylis, F. (2012). The self in situ: A relational account of personal identity. In J. Downie & J. Llewellyn (Eds.), Relational theory and health law and policy (pp. 109-131). Vancouver, Toronto: UBC Press. 14. Baylis, F. (2011). Gene-environment interaction: The gulf between what we know and what we do. In L. Maheu & R.A. Macdonald (Eds.), Challenging genetic determinism: New perspectives on the gene in its multiple environments. (pp.129-157). Montreal & Kingston: McGill-Queen’s University Press. 15. Baylis F. (2009). Creating humanesque embryos. In J. Nisker, F. Baylis, I. Karpin, C., McLeod & R. Mykitiuk (Eds.), The “healthy” embryo: Social, biomedical, legal and philosophical perspectives. Cambridge: Cambridge University Press. [amended version of Animal eggs for stem cell research: A path not worth taking. American Journal of Bioethics 8(12), 18-32.] 16. Baylis, F. (2008). Global norms in bioethics: Problems and prospects. In R.M., Green, A. Donovan, & S. A. Jauss (Eds.), Global bioethics: Issues of conscience for the twenty-first century (pp. 323-339). New York: Oxford University Press. 17. Baylis, F., Rodgers, S., & Young, D. (2008). Ethical dilemmas in the care of pregnant women: Rethinking 'maternal-fetal conflicts'. In P. A. Singer & A.M. Viens (Eds.), The Cambridge textbook of bioethics (pp. 97-103). Cambridge: Cambridge University Press. 18. Baylis, F. (2007). Of courage, honor, and integrity. In L.A. Eckenwiler, & F.G. Cohn (Eds.), The ethics of bioethics: Mapping the moral landscape (pp. 193-204). Baltimore: Johns Hopkins University Press.

Françoise BAYLIS (23 March 2020) Page 13 of 53 19. Baylis, F. (2006). Changing faces: Ethics, identity and facial transplantation. In D. Benatar (Ed.), Cutting to the core: Exploring the ethics of contested surgeries (pp. 155-167). Lanham, MD: Rowman and Littlefield. 20. Baylis, F., & Robert, J. S. (2005). Radical rupture: Exploring biological sequelae of volitional inheritable genetic modification. In J. E. J. Rasko, G. M. O'Sullivan, & R. A. Ankeny (Eds.), The ethics of inheritable genetic modification (pp. 131-148). Cambridge: Cambridge University Press. 21. Baylis, F., & Caniano D.A. (2005). Medical ethics and the pediatric surgeon. In K. T. Oldham, P. M. Colombani, R. P. Roglia, & M. A. Skinner (Eds.), Principles and practice of pediatric surgery (pp. 349-356). New York: Lippincott Williams and Wilkins. 22. Hellmann, J., & Baylis, F. (2005). Ethics in perinatal and neonatal medicine. In A. Fanaroff, & R. Martin (Eds.), Neonatal-perinatal medicine: Diseases of the fetus (8th ed., pp. 35-46). Philadelphia: Mosby, a Harcourt Health Sciences Company. 23. Baylis, F., &Brody, H. (2003). The Importance of Character for Ethics Consultants. In M. Aulisio, R. M. Arnold, & S. J. Youngner (Eds.), Doing ethics consultation: From theory to practice (pp. 37-44). Baltimore: John Hopkins Press. 24. Baylis, F., & Sherwin, S. (2002). Judgements of non-compliance in pregnancy. In D. Dickenson (Ed.), Ethical Issues in maternal-fetal medicine (pp. 285-301). Cambridge: Cambridge University Press. Excerpt pre-printed in: (2001). M. Parker, & D. Dickenson (Eds.), The Cambridge medical ethics workbook (pp. 68-74). Cambridge: Cambridge University Press. 25. Baylis, F. (2001). Human embryonic stem cell research: Comments on the NBAC report. In S. Holland, K. Lebacqz, & L. Zoloth (Eds.), The human embryonic stem cell debate: Science, ethics and public policy (pp. 51-60). Cambridge, MA: MIT Press. 26. Baylis, F., & Hellman, J. (2001). Ethics in perinatal and neonatal medicine. In A. A. Fanaroff, & R. J. Martin (Eds.), Neonatal-perinatal medicine: Diseases of the fetus and infant (7th ed., pp. 37-48). Philadelphia: Mosby, a Harcourt Health Sciences Company. 27. Baylis, F. (2000). Introduction: Three models of ethics consultation. In B. Freedman, & F. Baylis (Eds.), The roles and responsibilities of the ethics consultant: A retrospective analysis of cases (pp. 1-4). Hagerstown, Md: University Publishing Group. 28. Webster, G., & Baylis, F. (2000). Moral residue. In S. Rubin, & L. Zoloth (Eds.), Margin of error: The ethics of mistakes in the practice of medicine (pp. 217-230). Hagerstown, Md: University Publishing Group. (50% contribution) 29. Baylis, F., Downie, J., & Sherwin, S. (1999). Women and health research: From theory, to practice, to policy. In A. Donchin, & L. Purdy (Eds.), Embodying bioethics: Recent feminist advances (pp. 253- 268). New York: Rowman & Littlefield. Reprinted in: (2002). R. Chadwick, & D. Schroeder (Eds.), Applied ethics: Critical concepts in philosophy (Vol 1, pp140-154). London: Routledge. 30. Baylis, F., Downie, J., & Sherwin, S. (1998). Reframing research involving humans. In S. Sherwin, F. Baylis, M. Bell, M. DeKoninck, J. Downie, A. Lippman et al. (Eds.), The politics of women's health: Exploring agency and autonomy (pp. 234-259). Philadelphia: Temple University Press. Reprinted in: (2000). E. Boetzkes, & W. Waluchow (Eds.), Readings in health care ethics (pp. 433-449). Peterborough, Ont.: Broadview Press. 31. Baylis, F., & Caniano, D. (1997). Medical ethics and the pediatric surgeon. In K. T. Oldham, P. M. Colombani, & R. P. Foglia (Eds.), Surgery of infants and children: Scientific principles and practice (pp. 381-388). Philadelphia: Lippincott-Raven. Reprinted in: (2005) K. T. Oldham, P. M. Colombani, R. P. Foglia, M.A. Skinner (Eds.), Principles and Practice of pediatric Surgery, vols 1 & 2 (pp. 349- 356). Philadelphia: Lippincott Williams & Wilkins. 32. Baylis, F., & Downie, J. (1997). Child abuse and neglect: Cross-cultural considerations. In H. L. Nelson (Ed.), Feminism and families (pp. 173-187). New York: Routledge. 33. Baylis, F. (1994). A profile of the health care ethics consultant. In F. Baylis (Ed.), The health care ethics consultant (pp. 25-44). Totowa, NJ: Humana.

Françoise BAYLIS (23 March 2020) Page 14 of 53 34. Baylis, F. (1994). Introduction. In F. Baylis (Ed.), The health care ethics consultant (pp. 1-10). Totowa, NJ: Humana. 35. Baylis, F. (1993). Please sterilize my daughter. In F. Baylis, & C. McBurney (Eds.), In the case of children: Paediatric ethics in a Canadian context (pp. 156-158). Toronto: Department of Bioethics, The Hospital for Sick Children. 36. Baylis, F. (1993). Assisted reproductive technologies: Informed choice. In New reproductive technologies: Ethical aspects. Research Studies of the Royal Commission on New Reproductive Technologies (vol.1, pp. 47-147). Ottawa: Minister of Supply and Services Canada. 37. Baylis, F. (1989). Persons with moral expertise and moral experts: Wherein lies the difference? In B. Hoffmaster, B. Freedman, & G. Fraser (Eds.), Clinical ethics: theory and practice (pp. 89-99). New Jersey: Humana.

ENCYCLOPEDIA CONTRIBUTIONS (10) 1. Baylis, F. & Robert, J. S. (2014). Gene transfer. In: J. B. Holbrook and C. Mitcham (Eds) Ethics, Science, Technology, and Engineering: A Global Resource 2nd edition (Vol. 2, pp. 338-340). Farmington Hills, MI: Macmillan Reference USA. 2. Baylis, F. (2014). Infertility. Reference Module in Biomedical Sciences. 8pp. Elsevier. DOI: 10.1016/B978-0-12-801238-3.00268-3. 3. Baylis F. (2014). America, Bioethics in: II Canada. In: B. Jennings (Ed) Bioethics 4th Edition, (Vol. 1, pp. 203-211). Farmington Hills, MI: MacMillan Reference USA. 4. Baylis, F. (2013). Stem cell research. In: H. Lafollette (Ed) The International encyclopedia of ethics, pp.5011-5016. London, UK: Blackwell Publishing Ltd. DOI: 10.1002/ 9781444367072.wbiee451 5. Baylis, F. (2013). Embryo research. In: H. Lafollette (Ed) The International encyclopedia of ethics, pp. 1579-1585 London, UK: Blackwell Publishing Ltd. DOI: 10.1002/ 9781444367072.wbiee691 6. Baylis, F. (2012). Infertility. In: R. Chadwick (Ed) Encyclopedia of applied ethics 2nd Edition, (Vol. 2, pp. 712-720). San Diego: Academic Press USA. 7. Robert, J. S. & Baylis, F. (2008). Genetic engineering. In: K. Heggenhougen & S. Quah (Eds) International encyclopedia of public health, (Vol. 3, pp. 35-39). San Diego: Academic Press USA. 8. Baylis, F. & Robert, J. S. (2005). Gene therapy. In: C. Mitcham (Ed) Encyclopedia of science, technology and ethics (Vol. 2, pp. 829-831). Toronto: MacMillan Reference. 9. Baylis, F. (revision of D. Roy & J. Williams) (2004). Medical ethics, history of the Americas: III Canada. In: S.G. Post (Ed) Encyclopedia of bioethics 3rd Edition (Vol. 3 pp. 1540-1547). New York: MacMillan Reference USA. 10. Baylis, F. (1999). Informed consent and advanced infertility technologies. In: A. Burfoot (Ed) Encyclopedia of reproductive technologies (pp. 293-297). Colorado: Westview Press.

NON-REFEREED PUBLICATIONS (60) 1. Baylis, F., (2020). Rorotoko http://rorotoko.com/interviewee/baylis_francoise; http://rorotoko.com/interview/20200205_baylis_francoise_on_book_altered_inheritance_crispr_ethics _human 2. Baylis, F. (2019). Human genome editing: Our future belongs to all of us. Issues in Science and Technology 35(3), 42-44. https://issues.org/our-future-belongs-to-all-of-us/ 3. Lander, E., Baylis, F., Zhang, F. et al. (2019). Adopt a moratorium on heritable genome editing. Nature 567, 165-168. DOI: 10.1038/d41586-019-00726-5 https://www.nature.com/articles/d41586- 019-00726-5

Françoise BAYLIS (23 March 2020) Page 15 of 53 4. Baylis, F. (2019). Questioning the proposed translational pathway for germline genome editing. Nature Human Behaviour. 3, 200. DOI: 10.1038/s41562-019-0544-3. https://rdcu.be/bmc7S 5. Baylis, F. (2017). Human germline genome editing and broad societal consensus. Nature Human Behaviour 1, 0103. DOI: 10.1038/s41562-017-0103. http://rdcu.be/wpDR 6. Baylis, F. (2016). ‘Broad societal consensus’ on human germline editing. Harvard Health Policy Review 15(2), 19-23. 7. Baylis, F. (2016). Mitochondrial replacement techniques: ethical, social and policy considerations. RSC Reports from Abroad. https://rsc-src.ca/en/report-from-abroad/mitochondrial-replacement- techniques-ethical-social-and-policy-considerations 8. Baylis, F. and Rossant, J. (2016). This CRISPR moment: Editing human DNA the way we edit text – are we ready? Walrus Magazine. April, pp. 15-17 http://thewalrus.ca/this-crispr-moment/ 9. Baylis, F. (2015). Ethics and Assisted Reproduction Technologies in Canada: 2004-2014 Creating Families 10(1), 54-56. 10. Baylis, F., and Downie, J. (2014). Introduction. International Journal of Feminist Approaches to Bioethics 7(2), 1-9. 11. Baylis, F. (2014, Spring). Helping others learn from our mistakes VoxMeDAL: 53. 12. Baylis, F. (2013). The ethics of creating children with three genetic parents. Reproductive BioMedicine Online 26, 531-534. doi: http://dx.doi.org/10.1016/j.rbmo.2013.03.006 13. Baylis, F. (2012). The demise of Assisted Human Reproduction Canada [Guest Editorial] Journal of Obstetrics and Gynaecology Canada 34(6), 511-513. 14. Baylis, F. (2012). La fin de procréation assistée Canada [Editorial sollicité] Journal of Obstetrics and Gynaecology Canada 33(6), 514-516. 15. Bretzner, F., Gilbert, F., Baylis, F. & Brownstone, R. (2011). Subject selection for first first-in-human hESC-derived GNROPC1 research: A Response to Wirth et al. 2011. Cell Stem Cell. Available at http://www.cell.com/cell-stem-cell/comments/S1934-5909%2811%2900173-1 16. Baylis, F., & Downie, J. (2011). Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570]. Available at; http://www.bmj.com/content/342/bmj.d2570/reply (see responses) 17. Kaposy, C., & Baylis, F. (2011). The Common Rule, pregnant women, and research: No need to “rescue” that which should be revised. American Journal of Bioethics 11(5), 60-62. 18. Baylis, F. (2011). Supreme Court of Canada decision on the Assisted Human Reproduction Act creates urgent need for action [Guest Editorial]. Journal of Obstetrics and Gynaecology Canada 33(4), 317-319. 19. Baylis, F. (2011). Des mesures urgentes s’imposent à la suite de la décision de la Cour suprême du Canada quant à la Loi sur la procréation assistée [Editorial sollicité] Journal of Obstetrics and Gynaecology Canada 33(4), 320-322. 20. Baylis, F. (2010). Pregnant women deserve better. Nature 465, 689-690. 21. Baylis, F. (2009). Wir sind Schöpfer unserer selbst: wir sind stets genau das, was wir au suns selbst machen. [We are always exactly what we make ourselves] Das Magazin Nr. 8 (pp. 8 and 14). Also, Wir sind Schöpfer unserer selbst Ethische und soziale Überlegungen zum Enhancement [We are creators of ourselves: Ethical and social considerations for enhancement] pp. 173-178. https://d- nb.info/1012069583/04 22. Baylis, F., & Downie, J (2009). Drilling down in neuroethics. (Editorial) Bioethics 23(6), iii-iv. DOI: 10.1111/j.1467-8519.2009.01730.x

Françoise BAYLIS (23 March 2020) Page 16 of 53 23. Baylis, F., & Crozier, G. (2009). Postmenopausal reproduction: In whose interests? Journal of Obstetrics and Gynaecology Canada. 31(5), 457-458. 24. Fenton, A. Meynell, L., & Baylis F. (2009). Responsibility and speculation: On possible applications of pediatric fMRI. American Journal of Bioethics 9(1), W1-2. DOI: 10.1080/15265160802674424 25. Baylis, F. (2008). Choosing a path: Setting a course for the journey. American Journal of Bioethics 8(12), W4-6. DOI: 10.1080/15265160802659367 26. Baylis, F. (2008). Commentary in response to: ‘By what authority? Conflicts of interest in professional ethics. Journal of Ethics and Mental Health 3(2) http://www.jemh.ca/issues/v3n2/documents/JEMH_v3n02_1B_commentary_in_Response_By_What _Authority.pdf 27. Baylis, F., & Robert, J.S. (2007). Part-human chimeras: Worrying the facts, probing the ethics. American Journal of Bioethics 7(5), 41-45. DOI: 10.1080/15265160701290397 28. Baylis, F. (2007). Needed: A Modest Proposal. [Letter to the Editor] Hastings Center Report, 37(6), 8-9. 29. Reid, L., Johnston, J., & Baylis, F. (2006). Editorial from the Special Issue Editors. Journal of Bioethical Inquiry, 3(1/2): 11-13. DOI: 10.1007/s11673-006-9008-3 30. Baylis, F., & Robert, J.S. (2006). Primer on ethics and crossing species boundaries. American Institute of Biological Sciences http://www.actionbioscience.org/biotech/baylis_robert.html. 31. Baylis, F. (2005). Embryological viability. American Journal of Bioethics, 5, 17-18. DOI: 10.1080/15265160500318753 32. Baylis, F. (2005). Bioethics. In The Social Sciences and Humanities in Health Research: A Canadian Snapshot of Fields of Study and Innovative Approaches to Understanding and Addressing Health Issues (pp. 25-26). Ottawa: Canadian Institutes of Health Research. 33. Reid, L., & Baylis, F. (2005). Brains, genes, and the making of the self. American Journal of Bioethics, 5, 21-23. DOI: 10.1080/15265160590960401 Reprinted in: (2007) W. Glannon (Ed.) Defining Right and Wrong in Brain Science: Essential Readings in Neuroethics (pp.163-167). Dana Press. 34. Baylis, F. (2005). The impossible dream. University Affairs, (August-September), 14-16; L’impossible rêve. University Affairs, (August-September), 17-19. 35. Baylis, F., & Downie, J. (2005). An embryonic debate. Literary Review of Canada, 13(2), 11-13. 36. Baylis, F. (2004). A face is not just like a hand: Pace Barker. American Journal of Bioethics, 4, 30- 32. DOI: 10.1080/15265160490496804 37. Baylis, F. (2004). Canada bans human cloning. Hastings Center Report, 34, 5. 38. Ram N & Baylis, F. (2004). Embryons humains cryoconservés et recherche sur les cellules souches au Canada. L'Observatoire de la génétique. http://www.ircm.qc.ca/bioethique/obsgenetique/zoom/zoom_04/Z_no16_04/z_no16_04_01.html 39. Baylis, F., & Downie, J. (2003). The limits of altruism and arbitrary age limits. American Journal of Bioethics, 3, 19-21. DOI: 10.1162/152651603322614454 40. Robert, J. S., & Baylis, F. (2003). A response to commentators on "Crossing species boundaries". American Journal of Bioethics, 3(3), W-66. DOI: 10.1162/15265160360706417 41. Baylis, F. (2003). What is wrong with cloning humans? Journal of Health Services Research & Policy, 8, 192. 42. Baylis, F. (2002). Betwixt and between human stem cell guidelines and legislation. Health Law Review, 11, 44-50.

Françoise BAYLIS (23 March 2020) Page 17 of 53 43. Baylis, F. (2002). Canada announces restrictions on publicly funded stem cell research. Hastings Center Report, 32, 6-7. Excerpt pre-printed in: (2002). ‘Correction’. Stem Cell Research News, 4(2), 8. 44. Baylis, F. (2002). Invited feature. Human embryonic stem cell research. Canadian Chemical News, 54, 30-31. 45. Baylis, F. (2001). Brickbats and bouquets for the draft legislation on assisted human reproduction. Health Law Review, 10, 3-7. 46. Laidlaw, T., Baylis, F., Downie, J., MacLeod, H., & Ludman, M. D. (2001). The inclusion of ethics, law and communication issues in genetics education: A survey of Canadian medical schools [Special insert]. Canadian College of Medical Genetics Newsletter. 47. Baylis, F. (2001). Canadian regulation of assisted reproductive technologies? Hastings Center Report, 31, 8. 48. Baylis, F. (2000). The Canadian Biotechnology Advisory Committee. Hastings Center Report, 30, 52. 49. Baylis, F. (1999). Mandating research with children. IRB: A Review of Human Subjects Research, 21, 10-11. 50. Kenny N, & Baylis, F. (1998). Critical reflection and competent care: The ethics of practice [Invited editorial]. Echo Newsletter, The Medical Council of Canada, 9(2) (4pp). (50% contribution) 51. Baylis, F., & Weijer, C. (1997). Remembering Benjamin Freedman (1951-1997) [Invited editorial]. Hastings Center Report, 27, 48. 52. Baylis, F. (1997). Bioethics scholar remembered [Invited obituary]. Canadian Medical Association Journal, 156, 1679. Reprinted in: (2000). B. Freedman, [F. Baylis (Ed.], The Roles and Responsibilities of the Ethics Consultant: A Retrospective Analysis of Cases (p.153). Hagerstown, Md: University Publishing Group. 53. Baylis, F. (1993). When a child objects to medical treatment: The case of Philip [Feature article]. Ethics in Medical Practice, 3, 1-3, 5. Translated: L’opposition d’un enfant à un traitement médical. Le cas de Philippe. Ethics in Medical Practice, 3, 1-3, 5. 54. Baylis, F. (1992). Bill 109, an Act of respecting consent to treatment. Calyx: Ethical Issues in Paediatrics, 2, 1-2. 55. Baylis, F., & Downie, J. (1990). The nature of medical ethics. Westminster Affairs, 4, 11-12. 56. Baylis, F., & Downie, J. (1990). The new Canadian law on abortion. Westminster Affairs, 4, 10. 57. Baylis, F. (1989). Abortion: Recent Canadian history. Westminster Affairs, 2, 1-2. 58. Baylis, F. (1988). RU-486 update. Westminster Affairs, 2(1), 5. 59. Baylis, F. (1988). R. v. Morgentaler, S.C.C., Jan.28, 1988 [Unreported]. Westminster Affairs, 1, 5-6. 60. Baylis, F. (1988). What is RU-486? Westminster Affairs, 1, 4.

CORRESPONDENCE/ LETTERS TO THE EDITOR (20) 1. Baylis, F., (2020). To publish or not to publish. Nature Biotechnology https://doi.org/10.1038/s41587- 020-0435-1 2. Baylis, F., (2018). Canada’s prohibition on payment for surrogacy, eggs and sperm. Journal of Obstetrics and Gynaecology Canada DOI: 10.1016/j.jogc.2018.08.005 3. Baylis, F., & Ikemoto, L. (2017) .The Council of Europe and the Prohibition on Human Germline Genome Editing. EMBO Reports, 18(12), 2084-2085. DOI 10.15252/embr.201745343 4. Baylis, F. (2017). Re: Science needs your cells. The New York Times. Online and in print (April 28, 2017. https://www.nytimes.com/2017/04/28/opinion/cell-research-and-consent.html?_r=1

Françoise BAYLIS (23 March 2020) Page 18 of 53 5. Petropanagos, A., Cattapan, A., Baylis, F., & Leader A. (2016). Re: Potentially Misleading Representation of Live Birth Rate. Canadian Medical Association Journal http://www.cmaj.ca/content/187/9/666/tab-e-letters#re-potentially-misleading-representation-of-live- birth-rate 6. Baylis, F., & Herder, M. (2015). Who will implement WHO’s statement on public disclosure of trial results? Lancet 385, 2353-54. http://www.thelancet.com/journals/lancet/article/PIIS0140- 6736(15)61100-X/fulltext 7. Snow, D., Cattapan, A. and Baylis, F. (2015). Contesting estimates of cryopreserved embryos in the United States. Nature Biotechnology 33(9), 909. http://www.nature.com/nbt/journal/v33/n9/full/nbt.3342.html 8. Macklin, R., Shepherd, L., Dreger, A., & 42 others (including Baylis, F.) (2013). The OHRP and SUPPORT – Another View. [Letter to the Editor] NEJM June 26, DOI: 10.1056/NEJMc1308015. http://www.nejm.org/doi/full/10.1056/NEJMc1308015. 9. Baylis, F. (2012). Enforcing the Assisted Human Reproduction Act. Journal of Obstetrics and Gynaecology Canada 34(5), 415. 10. Baylis, F. & Kaposy, C. (2011). Ideal ethical standards for contraceptive use in research. IRB: Ethics & Human Research, 33(2), 19-20. 11. Baylis, F., & Ram, N. (2006). Eligibility of cryopreserved human embryos for stem cell research in Canada the importance of empirical research in bioethics: The case of human embryo stem cell research: in response. Journal of Obstetrics and Gynaecology Canada, 28, 15-16. 12. Baylis, F. (1998). Presumed consent? Let's not be presumptuous! Canadian Medical Association Journal, 159, 135. 13. Baylis, F., & Nelson, H.L. (1997). Access to health care for women. New England Journal of Medicine, 336, 1841. 14. Nisker, J. A., & Baylis, F. (1994). The best of us. Fertility and Sterility, 62, 893-894. (50% contribution) 15. Baylis, F., & Downie, J. (1994). Sentence - Education in ethics - Reply. Canadian Medical Association Journal, 151, 416-417. 16. Baylis, F., Downie, J., & Litt, M. (1994). Sentence - Education in ethics. Canadian Medical Association Journal, 150, 1195. 17. Baylis, F., & Downie, J. (1993). Sentence - Education in ethics - Reply. Canadian Medical Association Journal, 149, 1772. 18. Baylis, F., & Downie, J. (1993). Sentence: Education in ethics. Canadian Medical Association Journal, 149, 532, 536. 19. Baylis, F. (1993). Screening for genetic-disease - Reply. Canadian Medical Association Journal, 149, 393. 20. Baylis, F., Downie, J., & Sherwin, S. (1990). Medical ethics and women. Canadian Medical Association Journal, 143, 250-251.

BLOGS (51) 1. Baylis, F. (2020, March 24) Coronavirus: The watchword is solidarity, not autonomy Impact Ethics https://impactethics.ca/2020/03/24/coronavirus-the-watchword-is-solidarity-not-autonomy/ 2. Baylis, F. (2020, March 16) Coronavirus: When Canadian compassion requires social distancing. The Conversation https://theconversation.com/coronavirus-when-canadian-compassion-requires- social-distancing-133712

Françoise BAYLIS (23 March 2020) Page 19 of 53 3. Baylis, F. (2020, March 10) Coronavirus in Vietnam: Observations from a Canadian. Impact Ethics https://impactethics.ca/2020/03/10/coronavirus-in-vietnam-observations-from-a-canadian/ 4. Baylis, F. (2020, Jan 5) Prison sentence for creator of first CRISPR babies reignites ethical debate. The Conversation https://theconversation.com/prison-sentence-for-creator-of-first-crispr-babies- reignites-ethical-debate-129268 5. Baylis, F. (2019, Dec 10) A Year after the first CRISPR babies, stricter regulations are now in place. The Conversation https://theconversation.com/a-year-after-the-first-crispr-babies-stricter-regulations- are-now-in-place-128003 Reprinted in French (2019, Dec 19) Un an après les premiers bébés CRISPR, des norms plus strictes sont en place pour éviter les dérives https://theconversation.com/un-an-apres-les-premiers-bebes-crispr-des-normes-plus-strictes-sont- en-place-pour-eviter-les-derives-128767 6. Kofler,N., Baylis F., Dellaire G., & Getz, L. (2019, October 1) Genetically modifying mosquitoes to control the spread of disease carries unknown risks. The Conversation https://theconversation.com/genetically-modifying-mosquitoes-to-control-the-spread-of-disease- carries-unknown-risks-123862 Reprinted 7. Baylis, F. (2019, September 18) The CRISPR dream. Impact Ethics https://impactethics.ca/2019/09/18/the-crispr-dream/ 8. Baylis, F. (2019, April 3) Why avoid the “M-Word” in human genome editing? Bioethics Forum https://www.thehastingscenter.org/why-avoid-the-m-word-in-human-genome-editing/ 9. Baylis, F. & Darnovsky, M. (2019, January 17) Scientists disagree about the ethics and governance of human germline editing Bioethics Forum https://www.thehastingscenter.org/scientists-disagree- ethics-governance-human-germline-genome-editing/ 10. Getz, L., Dellaire G., & Baylis, F. (2018, December 10) Jiankui He: A Sorry tale of high-stakes science. Bioethics Forum https://www.thehastingscenter.org/jiankui-sorry-tale-high-stakes-science/ 11. Baylis, F., Dellaire G., & Getz, L. (2018, November 27) Why we are not ready for genetically designed babies. The Conversation http://theconversation.com/why-we-are-not-ready-for- genetically-designed-babies-107756 Reprinted 12. Baylis, F. (2018, November 26) First CRISPR babies: Where are our ethics? Impact Ethics https://impactethics.ca/2018/11/26/first-crispr-babies-where-are-our-ethics/ 13. Baylis, F. (2018, October 29) Reimbursing surrogates and donors. Impact Ethics. https://impactethics.ca/2018/10/29/reimbursing-surrogates-donors/ 14. Baylis, F., & Cattapan, A. (2018, April 2) Paying surrogates, sperm and egg donors goes against Canadian values. The Conversation. https://theconversation.com/paying-surrogates-sperm-and-egg- donors-goes-against-canadian-values-94197 Reprinted 15. Baylis, F. (2018, April 2) Let’s ask a different question about surrogacy. Impact Ethics. https://impactethics.ca/2018/04/02/lets-ask-a-different-question-about-surrogacy/ 16. Baylis, F. (2017, October 24) Gene editing technology: Where should we draw the line? Healthy Debate http://healthydebate.ca/opinions/gene-editing-technology Reprinted in Impact Ethics and the Center for Genetics and Society. 17. Baylis, F., & Cattapan, A. (2017, October 2) Canada’s prohibition on altering the human genome. Impact Ethics. https://impactethics.ca/2017/10/02/canadas-prohibition-on-altering-the-human- genome/ 18. Baylis, F. (2017, October 1) Genome editing of human embryos broadens ethics discussion. The Conversation. https://theconversation.com/genome-editing-of-human-embryos-broadens-ethics- discussions-84888 Reprinted 19. Cattapan, A., & Baylis F. (2017, September 27) Egg donors and surrogates need high-quality care. The Conversation. https://theconversation.com/egg-donors-and-surrogates-need-high-quality-care- 84664 Reprinted

Françoise BAYLIS (23 March 2020) Page 20 of 53 20. Baylis, F. (2017, August 1) Human genome editing: We should all have a say. The Conversation. https://theconversation.com/human-genome-editing-we-should-all-have-a-say-81797 Reprinted 21. Baylis, F. (2017, May 19) The ethics of in vitro gametogenesis. Impact Ethics. https://impactethics.ca/2017/05/19/the-ethics-of-in-vitro-gametogenesis/ 22. Baylis, F. (2017, February 17) Human germline genome editing: An ‘impressive’ sleight of hand? Impact Ethics. https://impactethics.ca/2017/02/17/human-germline-genome-editing-an-impressive- sleight-of-hand/ 23. Caluwaerts, S., & Baylis, F. (2016, November 25) Nubia – An Ebola survivor orphaned by vaccine policy. Impact Ethics. https://impactethics.ca/2016/11/25/nubia-an-ebola-survivor-orphaned-by- vaccine-policy/ 24. Baylis, F. (2016, September 28) Insurance companies shouldn’t access genetic test results. Healthy Debate. http://healthydebate.ca/opinions/genetic-tests-discrimination-law-canada 25. Baylis, F. (2016, September 26) Risky business: Genetic discrimination & insurance. Impact Ethics https://impactethics.ca/2016/09/26/risky-business-genetic-discrimination-insurance/ 26. Baylis, F. (2016, September 1) Human-nonhuman chimera research in Canada. Impact Ethics https://impactethics.ca/2016/09/01/human-nonhuman-chimera-research-in-canada/ 27. Baylis, F. (2016, May 5) Pushing the 14-day limit on human embryo research. Impact Ethics https://impactethics.ca/2016/05/05/pushing-the-14-day-limit-on-human-embryo-research/ Reprinted in French Recherche sur l’embryon: faut-il aller au-delà des 14 jours? Le Monde (2016, May 11) 28. Baylis, F. (2016, February 25-March 6) @NEJM Ask the Authors & Experts: Mitochondrial Replacement Techniques--Implications for the Clinical Community. NEJM Group Open Forum. https://medstro.com/groups/nejm-group-open-forum/discussions/230 29. Baylis, F. (2016, February 12) Human Gene Editing: A Global Discussion. Impact Ethics https://impactethics.ca/2016/02/12/global-response-to-human-gene-editing/ 30. Baylis, F. (2016, February 3) A cautious approach to mitochondrial replacement. Impact Ethics https://impactethics.ca/2016/02/03/a-cautious-approach-to-mitochondrial-replacement/ 31. Baylis, F. (2016, January 12) Still Alice meets still Gloria. Impact Ethics http://impactethics.ca/2016/01/12/still-alice-meets-still-gloria/ 32. Baylis, F. (2015, February 23) The truth about mitochondrial replacement. Impact Ethics http://impactethics.ca/2015/02/23/the-truth-about-mitochondrial-replacement/ 33. Baylis, F. (2014, December 8) Will Quebec’s cut to IVF funding lead to more multiple pregnancies? Healthy Debate http://healthydebate.ca/opinions/quebec-continues-regulate-embryos-transferred- per-cycle 34. Baylis, F. (2014, December 2) Kudos to Quebec IVF docs for reducing the # of multiple pregnancies Impact Ethics http://impactethics.ca/2014/12/02/kudos-to-quebec-ivf-docs-for-reducing-the-of- multiple-pregnancies/ 35. Baylis, F. (2014, October 16) Left out in the cold: Seven reasons not to freeze your eggs Impact Ethics http://impactethics.ca/2014/10/16/left-out-in-the-cold-seven-reasons-not-to-freeze-your-eggs/ Reposted: (2014 October 17) IJFAB The Blog http://www.ijfab.org/blog/left-out-in-the-cold-seven- reasons-not-to-freeze-your-eggs/; (2014, October 20) Healthy Debate http://healthydebate.ca/opinions/left-cold-seven-reasons-freeze-eggs 36. Baylis, F., & Downie J. (2014, July 2) Silencing ethics at CIHR Impact Ethics http://impactethics.ca/2014/07/02/silencing-ethics-at-cihr/ 37. Baylis, F., & Downie J. (2014, February 25) “Mayday, Mayday, Mayday” for ethics at CIHR Impact Ethics http://impactethics.ca/2014/02/25/mayday-mayday-mayday-for-ethics-at-cihr/

Françoise BAYLIS (23 March 2020) Page 21 of 53 38. Baylis, F., & Downie, J. (2013, December 17) Wishing doesn’t make it so Impact Ethics http://impactethics.ca/2013/12/17/wishing-doesnt-make-it-so/ 39. Baylis, F. (2013, December 2) “Apparently everywhere, but really nowhere” Impact Ethics http://impactethics.ca/2013/12/02/apparently-everywhere-but-really-nowhere/ 40. Baylis, F. (2013, October 28) The multiple meanings of futility Impact Ethics http://impactethics.ca/2013/10/28/the-multiple-meanings-of-futility/ 41. Herder, M., & Baylis, F. (2013, August 6) Policy laundering and payment for plasma Impact Ethics http://impactethics.ca/2013/08/06/policy-laundering-and-payment-for-plasma/ 42. Baylis, F. (2013, July 2) Ethical objections to mitochondrial replacement Impact Ethics http://impactethics.ca/2013/07/02/ethical-objections-to-mitochondrial-replacement/ 43. Baylis, F. (2013, June 26) The ethics of spending millions on high-tech pregnancies: ‘Made in Quebec’ Impact Ethics http://impactethics.ca/2013/06/26/the-ethics-of-spending-millions-on-high- tech-pregnancies-made-in-quebec/ 44. Baylis, F., & Tonkens, R. (2013, April 25) Milking women. Impact Ethics http://impactethics.ca/2013/04/25/milking-women/ 45. Baylis, F. (2013, April 4) Impact ethics: Making a difference. Impact Ethics http://impactethics.ca/2013/04/page/2/ 46. Baylis, F. (2013, April 3) Change my mind: Should there be an age limit for fertility treatments? The Blog, Huffington Post Canada, http://www.huffingtonpost.ca/marni-soupcoff/fertility-treatment-age- limit_b_3001399.html 47. Baylis, F. (2012, May 1) Are Canadian fertility services breaking the law? Bioethics Forum. http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=5815&blogid=140 48. Baylis, F. (2012, March 20) The hazards of fast science. Bioethics Forum. http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=5780&blogid=140 49. Baylis, F. (2011, December 2) Geron’s discontinued stem cell trial: What about the research participants? Bioethics Forum. https://www.thehastingscenter.org/gerons-discontinued-stem-cell- trial-what-about-the-research-participants/ 50. Baylis, F., & Crozier, G. (2009, February 18) Children at all costs? Bioethics Forum. https://www.thehastingscenter.org/children-at-all-costs/ 51. Baylis, F. (2008, March 4) ES Cells and iPS Cells: A distinction with a difference. Bioethics Forum. https://www.thehastingscenter.org/es-cells-and-ips-cells-a-distinction-with-a-difference/

NEWS MEDIA (40)

1. Baylis, F. Scientific ethics and gene edited babies (2020, Jan 5) The Boston Globe https://www.bostonglobe.com/2020/01/05/opinion/scientific-ethics-gene-edited-babies/

2. Baylis, F. Before heritable genome editing, we need slow science and dialogue ‘within and across nations.’ (2019, September 23) STAT News https://www.statnews.com/2019/09/23/genome-editing- slow-science-dialogue/

3. Baylis, F. Paying for egg donations enters dicey territory. (2018, June 3) Ottawa Citizen http://ottawacitizen.com/opinion/columnists/baylis-paying-for-egg-donations-enters-dicey-territory Reprinted in Impact Ethics

4. Baylis, F. Why paying for sperm won’t solve our problems. (2018, May 28) Ottawa Citizen http://ottawacitizen.com/opinion/columnists/baylis-why-paying-for-sperm-wont-solve-our-problems

Françoise BAYLIS (23 March 2020) Page 22 of 53

5. Cattapan, A., & Baylis, F. (2018, May 1) Argument of paying for surrogacy, sperm and eggs based on misinformation. The Toronto Star https://www.thestar.com/opinion/contributors/2018/05/01/no- proposed-changes-to-the-law-are-based-on-misinformation.html 6. Baylis, F. (2016, May 4) Ethics panel: Scientists break record for lab-grown human embryos, raising questions over research rules. GENeS Genetic Expert News Service http://geneticexperts.org/scientists-break-record-for-lab-grown-human-embryos-raising-questions- over-research-rules 7. Cattapan, A., & Baylis, F. (2016, April 9) The trouble with paying for sperm. The Toronto Star http://www.thestar.com/opinion/commentary/2016/04/09/the-trouble-with-paying-for-sperm.html (http://bit.ly/1oRdbU8) 8. Cattapan, A., & Baylis, F. (2016, March 12). Don’t commercialize women’s bodies. [Letter to the Editor] The Montreal Gazette http://www.pressreader.com/canada/montreal- gazette/20160312/281754153426235 9. Baylis, F. (2016, February 3) Ethics panel: US should allow embryos with mitochondrial DNA from a third person. GENeS Genetic Expert News Service http://geneticexperts.org/ethics-panel-us-should- allow-embryos-with-mitochondrial-dna-from-a-third-person/ 10. Baylis, F. (2013, April 5) Oocyte Donation – Aged Parents. The Mark News 11. Jones, D., Baylis, F., McCormick, R., Kollek, R. & Lopéz-Moratalla, N. (2013, March 20). [Letter to the Editor] Alarm over genetic control of embryos. The Times (London, UK). 12. Baylis, F. (2013, February 27) Who’s Paying for IVF? The Mark News 13. Baylis, F., & Tonkens, R. (2013, January 25) Wombs and breasts for rent: What next? The Mark News 14. Baylis, F. (2012, July 13) Say No to public funding of IVF O.Canada.com http://o.canada.com/2012/07/13/say-no-to-public-ivf-funding/ 15. Baylis, F. (2012, April 5) A mixed bag budget. The Mark News. 16. Baylis, F. (2012, March 20) Knowledge: The best return on investment. The Mark News. 17. Baylis, F. (2012, March 07) Comment on “If Canada’s game is hockey, its science is stem cells.” Globe and Mail. 18. Baylis, F. (2011, November 25) Where research ethics meets profit margins. The Mark News. 19. Baylis, F. (2011, September 23) Win a baby, lose your morals. The Mark News. 20. Baylis, F. (2011, May 28) A victory for the right to know. The Mark News. Reprinted in: Health Law Matters (complement to Canadian Health Facilities Law Guide), June 2011, No. 232, 1-2. 21. Baylis, F. (2010, October 26) DEBATE: Is genetic engineering a threat to humanity? The Mark News. 22. Baylis, F. (2010, October 6) The forgotten rights of donor offspring. The Mark News. 23. Baylis, F. (2010, January 15) An unnecessary risk. The Mark News. 24. Baylis, F. (2009, December 3) An intractable conflict of interest. The Mark News. Reprinted in: Open Medicine Available: http://www.longwoods.com/content/21200 25. Baylis, F. (2009, November 13) (with Noni MacDonald). The facts about H1N1. The Mark News. 26. Baylis, F. (2009, October 22). (with Noni MacDonald). Should you take the H1N1 vaccine? The Mark News 27. Baylis, F. (2009, August 12). Aid by vaccine. The Mark News.

Françoise BAYLIS (23 March 2020) Page 23 of 53 28. Baylis, F. (2009, August 6). How much vaccine to order and who gets it? Globe and Mail. http://www.theglobeandmail.com/news/opinions/how-much-vaccine-to-order-and-who-gets- it/article1242268/ 29. Baylis, F. (2009, July 3). Making babies one at a time. The Mark News. 30. Baylis, F. (2009, May 5) Why girls shouldn’t be guinea pigs. The Mark News. 31. Baylis, F. (2009, May 4). Baby-making technologies: Fertile field for federal or provincial oversight? Globe and Mail. 32. Baylis, F., McLeod, C., Nisker, J., & Sherwin, S. (2007, January 16). Nothing extreme about protecting fresh embryos. Globe and Mail, p. A15. 33. Robert, J.S., & Baylis, F. (2005, July 4). When it comes to funding research, value should count. Globe and Mail, p. A13. 34. Baylis, F., & Downie, J. (2003, February 3). Cloning for stem cell research unnecessary and dangerous. The Hill Times, p. 16. Reprinted in: (2003, February). CellLines, 2, 3-4; (2003, March); and The Bulletin, The Genetics Society of Canada, 34(1), 21-23. 35. Baylis, F., & Downie, J. (2002, July 3). Ban cloning. Do you copy? Globe and Mail, p. A13. 36. Baylis, F. (2002, May 6). Parliament's call for moratorium on stem cell research perplexing. The Hill Times, p. 30. 37. Baylis, F. (2002, March 2). Our ethics are embryonic. Globe and Mail, p. A17. 38. Baylis, F., & Kyle, T. (1989, December 19). Weighing the consequences of breaching confidentiality. The Medical Post, p. 8. 39. Baylis, F., & Downie, J. (1989, November 25). Ensuring freedom to say no. London Free Press, p. A13. 40. Baylis, F., & Downie, J. (1989, November 23). Avoid undue pressure to donate organs. The Gazette, p. B4.

BOOK/ARTICLE REVIEWS (11) 1. Baylis, F. (1999). Effect of exposure to 15% oxygen on breathing patterns and oxygen saturation in infants: Interventional study. In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 242-244). Chicago: Mosby. 2. Baylis, F. (1999). Decision-making in the critically ill neonate: Cultural background v. individual life experience. In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 353-355). Chicago: Mosby. 3. Baylis, F. (1999). Analysis of clinical bioethics teaching in pediatric surgery residency. In A. A. Fanaroff & M. J. S. D. K. Maisels (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 355- 356). Chicago: Mosby. 4. Baylis, F., & Bolton, M. (1998, December 20). [Review of book What Remains to Be Discovered: Mapping the Secrets of the Universe, the Origins of Life and the Future of the Human Race]. CBC, Quirks and Quarks. 5. Baylis, F. (1998). Resource allocation in neonatal and medical ICUs: Epidemiology and rationing at the extremes of life. In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 395-398). Chicago: Mosby. 6. Baylis, F. (1998). Is venepuncture in neonatal research ethical? In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 402-404). Chicago: Mosby.

Françoise BAYLIS (23 March 2020) Page 24 of 53 7. Baylis, F. (1998). Determinants of parental authorization for involvement of newborn infants in clinical trials. In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 404-406). Chicago: Mosby. 8. Baylis, F. (1997). Resolving the clinical and ethical dilemma involved in fetal-maternal conflicts. In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 442-443). Chicago: Mosby. 9. Baylis, F. (1997). Common ethical dilemmas encountered in the management of HIV-infected women and newborns. In A. A. Fanaroff, M. J. Maisels, & D. K. Stevenson (Eds.), Year Book of Neonatal and Perinatal Medicine (pp. 443-445). Chicago: Mosby. 10. Baylis, F. (1995). An egalitarian ethic: Balancing rights and responsibilities [Review of the book Women and Children in Health Care: An Unequal Majority]. Medical Humanities Review, 9, 48-51. 11. Baylis, F. (1993). Should children have the same rights as adults? [Review of the book In Their Best Interest: The Case Against Equal Rights for Children]. Medical Humanities Review, 7, 68-72.

PRESENTATIONS

PODCASTS (8) 1. #178 Germline Ethics The Week in Health Law. March 16, 2020 https://www.podbean.com/media/share/pb-29yir-d3e73a? 2. #9 Personalized Medicine Sciencetown. February 26, 2020 https://www.iheart.com/podcast/269- sciencetown-49635528/episode/9-personalized-medicine-58265073/ 3. #WEP2020 Interview with Françoise Baylis, Host Nicholas Demille January 14, 2020 https://www.youtube.com/watch?v=15rIrK0dCsQ 4. Gene Editing, Slow Science and Public Engagement. Carnegie Council for Ethics in International Affairs. December 18, 2019 https://www.carnegiecouncil.org/studio/multimedia/20191218-gene- editing-slow-science-francoise-baylis 5. The Human Genome Belongs to You. Genome Alberta. September 27, 2019 http://www.genomealberta.ca/files/podcasts/genomics/mp3s/Baylis_final_edit.mp3 6. #11 What is CRISPR? Françoise Baylis talks futurism, gene-edited babies, and bioethics. Empowered Health. June 3, 2019 https://podcasts.apple.com/us/podcast/ep-11-what-is-crispr- francoise-baylis-talks-futurism/id1452440833?i=1000440410557 7. #105 Françoise Baylis: The Ethics of CRISPR-cas9 Gene Editing Technology. The Dissenter. November 29, 2018 https://www.youtube.com/watch?v=qSdPb-vvbpE 8. #104 Françoise Baylis – Impact Ethics. Simulation. May 19, 2018 https://www.youtube.com/watch?v=pOb5YeOU93A

REFEREED PRESENTATIONS (INTERNATIONAL) (48) 1. Reasons not to Invest Time Talent and Treasure in Human Nuclear Genome Transfer (So-called Mitochondrial Replacement) 14th World Congress of Bioethics, Bangalore, India, 6 December 2018. 2. Personalised Medicine: An Emergent Threat to Public Health. 13th International Conference on Feminist Approaches to Bioethics, Bangalore, India, 4 December 2018. 3. Identity, Alzheimer’s and End-of-life Care. XXXVth International Congress on Law and Mental Health, Faculty of Law Charles University, Prague, 13 July 2017. 4. What should we do About Human Gene Editing? Making Science Policy with People who Don’t Trust Science. AAAS Annual Meeting. Boston, Massachusetts, 19 February 2017. 5. “She is who she is” Alzheimer’s and Identity.11th Congress on Feminist Approaches to Bioethics, Edinburgh, Scotland, 13 June 2016.

Françoise BAYLIS (23 March 2020) Page 25 of 53 6. Pregnant Women and Health Research: Challenges and Solutions. 11th Congress on Feminist Approaches to Bioethics, Edinburgh, Scotland, 13 June 2016 (with A. Ballantyne and C. Ells). 7. Research Involving Pregnant Women. American Society for Bioethics and Humanities, Annual Meeting, Washington DC., U.S.A. 18 October 2012. 8. Ethically Sound Research Involving Pregnant Women. Panel: Fair Inclusion of Pregnant Women in Research. 11th International Congress of Bioethics, Rotterdam, Netherlands, 27 June 2012 (with A. Ballantyne, R. Macklin and R. Faden). 9. Do Donors and Non-Donors Have Different Moral Values? Panel: Ethical Challenges in the Uses of Human Reproductive Tissue in Scientific Research Procurement and Protection? 11th International Congress of Bioethics, Rotterdam, Netherlands, 27 June 2012 (with E. Haimes, S. De Lacey and C. Walby). 10. Ethically Sound Research Involving Pregnant Women. Panel: A Just Research Agenda for Pregnant Women Supporting Appropriate Health Care Now and in the Future. 9th International Conference on Feminist Approaches to Bioethics, Rotterdam, Netherlands, 26 June 2012 (with A. Ballantyne and R. Macklin). 11. Personal Identity: The Promise and Threat of Deep Brain Stimulation. Australasian Association of Bioethics and Health Law, Brisbane, Australia, 8 July 2011. 12. A Relational Account of Personal Identity. Australasian Association of Philosophy, Dunedin, New Zealand, 4 July 2011. 13. The Impact of Relational Identity for the Ethical Evaluation of Brain-Machine Interfaces. Panel: Bonding Brain to Machines: Ethical Issues of Brain-Machine Interfaces. 10th International Congress of Bioethics, Singapore, 28 July 2010 (with J. Clausen, G. Wolbring, B. Gordjin) 14. Patients Beyond Borders: Shopping for Fertility Treatment. Panel: You’ve Come a Long Way, Baby: Ethical Considerations in Cross-Border Reproductive Travel. 8th International Conference on Feminist Approaches to Bioethics, Singapore, 26 July 2010 (with G. Crozier, D. Martin). 15. Ethics and Neuroscience Research in Developing Countries. 38th Annual Meeting of the Society for Neuroscience. Social Issues Roundtable: Global Neuroscience – Neuroethics and the Burden of Nervous System Disorders, Washington, DC, November 2008. 16. Slippery Slopes and Cytoplasmic Hybrid Embryo Research. 10th Annual Meeting of the American Society for Bioethics and Humanities, Cleveland, OH, October 2008. 17. Plenty Cheap: Animal Eggs for Human Embryonic Stem Cell Research. 9th International Congress of Bioethics, Rijeka, Croatia, September 2008. 18. Feminist Relational Theory: An Essential Component of Pandemic Planning. 7th International Conference on Feminist Approaches to Bioethics and 9th International Congress of Bioethics, Rijeka, Croatia, September 2008 (with N. Kenny and S. Sherwin). 19. Using Nonhuman Animal Oocytes to Improve Assisted Human Reproduction: A Woman’s Choice? 7th International Conference on Feminist Approaches to Bioethics, Rijeka, Croatia, September 2008. 20. Defining Values for Bioethics and Bioethicists: Continuing the Dialogue. Panel. 9th Annual Meeting of the American Society for Bioethics and Humanities, Washington DC, October 2007 (with L. Eckenwiler, V. Ashby Sharpe, L. Turner, and F. Cohn). 21. Neuroenhancement: Psychopharmacology and Beyond. Panel. 9th Annual Meeting of the American Society for Bioethics and Humanities, Washington, D.C., October 2007 (with W. Glannon, E. Racine and R. Bondar). 22. Should Women Be Paid to Provide Eggs for Stem Cell Research? Feminist Ethics and Social Theory (FEAST) Conference, Clearwater Beach, Florida USA, September 2007 (with C. McLeod). 23. Chimera Research for Degenerative Brain Disorders. 8th Annual Meeting of the American Society for Bioethics and Humanities, Denver, Colorado, October 2006. 24. Fresh or Frozen Embryos: Which is best for Embryo Donors? 6th International Conference on Feminist Approaches to Bioethics, Beijing, China, August 2006 (with C. McLeod). 25. Ethics, Embryos and the Art of Finesse. AAAS, (Panel on Stem Cells and Society: Assessing a Grand Challenge) St Louis, Missouri, February 2006. 26. Guidelines for Embryonic Stem Cell Research in CF: Two Countries, Two Similar Views. 28th European CF Conference, Crete, Greece, June 2005 (with N. Ram, M. Mélancon, & M. De Braekeleer). 27. Stem Cells and Big Picture Bioethics: Comparing Policy Making in Liberal Democracies. 7th World Congress of Bioethics, Sydney, Australia, November 2004 (with S. Dodds, R. Ankeny, & J. Downie).

Françoise BAYLIS (23 March 2020) Page 26 of 53 28. Can Embryos Really be Commodified? International Network on Feminist Approaches to Bioethics, Sydney, Australia, November 2004 (with C. McLeod). 29. Regulating Genetic and Reproductive Technologies: Canadian and American Perspectives. Joint Meeting American Society for Bioethics and Humanities and Canadian Bioethics Society, Montréal, Québec, October 2003 (panel with T. Caulfield and L. Knowles). 30. Confusion about Crossing Species Boundaries: Scientific, Ethical and Social Aspects of Chimaera Making in Stem Cell Biology. Transvision 2003, Yale University, New Haven, Connecticut, June 2003 (with J. S. Robert). 31. Identity and the Human Genome Project: The Species Problem. 6th World Congress of Bioethics, Brasilia, Brazil, November 2002 (with J. S. Robert). 32. Ethics Consultation: Policies and Politics. International Association of Bioethics Network on Feminist Approaches to Bioethics, 4th International Conference on Feminist Approaches to Bioethics, Brasilia, Brazil, October 2002 (with S. Sherwin). 33. The Public Face of Bioethics; Watchdog or Show Dog? 4th Annual Meeting of the American Society for Bioethics and Humanities, Fifth Annual Meeting, Baltimore, USA, October 2002. 34. Genetic Enhancement Technologies: Imminent, Inevitable, or Inescapable? Society for Social Studies of Science. Cambridge MA, November 2001 (with J. S. Robert). 35. Stability, Rupture and the Human Genome. 3rd Annual Meeting of the American Society for Bioethics and Humanities, 4th Annual Meeting, Nashville, USA, October 2001 (with J. S. Robert). 36. Stability, Rupture and the Human Genome. International Bioethics Retreat, 4th Annual Meeting, Paris, France, May 2001 (with J. S. Robert). 37. Human Enhancement Technologies. 5th World Congress of Bioethics, London, U.K. September 2000. 38. Human Cloning: Three Mistakes and a Solution. International Bioethics Retreat, Second Annual Meeting, Florence, Italy, October 1999. 39. Defining the Boundaries of “Respect”. Bioethics Summer Retreat, Eleventh Annual Meeting, Hot Springs, Virginia, June 1999 (with C. Weijer). 40. Pregnant Women and Substance Abuse: A Recent Supreme Court of Canada Decision. International Association of Bioethics, Fourth World Congress, Tokyo, Japan, November 1998. 41. Women and Health Research: New Canadian Research Guidelines. International Association of Bioethics Network on Feminist Approaches to Bioethics, 2nd International Conference on Feminist Approaches to Bioethics, Tsukuba, Japan, November 1998 (with J. Downie). 42. Taking Ourselves to Task: A Session in Tribute to Benjamin Freedman. Joint Meeting of the American Association of Bioethics, Society for Bioethics Consultation, Society for Health and Human Values, Annual Meeting, Baltimore, Maryland, November 1997. 43. Reflections on Autonomy, Agency, and Resistance. International Association of Bioethics Network on Feminist Approaches to Bioethics, First International Conference on Feminist Approaches to Bioethics, San Francisco, California, November 1996. 44. Development of a Postgraduate Medical Ethics Curriculum: A Canadian Model for Pediatrics -- Pedagogic Methods and Tools. Third World Congress, International Association of Bioethics, San Francisco, California, November 1996. 45. Consultation and Cross-cultural Conflict: A Choice for K'aila. Society for Bioethics Consultation, Annual Meeting, Cleveland, Ohio, September 1995. 46. The 'Good' Physician: Pediatric Ethics Education. Society for Health and Human Values, Spring Annual Meeting, Chicago, Illinois, April 1995 (with N. Kenny). 47. Children and Consent to Treatment. Society for Health and Human Values, Spring Annual Meeting, Galveston, Texas, May 1993. 48. Ethics Consultation by Committee, by Consultant, by ... Society for Bioethics Consultation, Annual Meeting, Toronto, Ontario, September 1991.

INVITED PRESENTATIONS (INTERNATIONAL) (86) 1. Altered Inheritance: CRISPR and the Ethics of Human Genome Editing. Hall Center for Law and Health: McDonald-Merrill-Ketcham Award Lecture. Indianapolis, Indiana, 14 February 2020. 2. Altered Inheritance: CRISPR and the Ethics of Human Genome Editing. Keystone Symposia Workshop: Ethics of Genome Editing, Banff, Alberta, 9 February 2020.

Françoise BAYLIS (23 March 2020) Page 27 of 53 3. Heritable Genome Editing: People, Power and Place. The Conversation, Center for Biology and Society, Arizona State University, Phoenix, Arizona, 5 February 2020. 4. Heritable Human Genome Editing--Scientists and Science Policy. KAUST Winter Enrichment Program. Saudi Arabia, 15 January 2020. 5. Heritable Human Genome Editing--Scientists and Science Policy (EMBO Science Policy Lecture). Facing the Future: Challenges and Perspectives of Life Sciences in the 21st century. 21st EMBL PhD Symposium. EMBL Heidelberg, Germany 28-30 November 2019. 6. Heritable Human Genome Editing: And What about the Women? Policy, Ethics and Life Sciences 20th Anniversary Celebration, Newcastle, United Kingdom, 21 November 2019. 7. ‘Broad Societal Consensus’: Public Education, Engagement and Empowerment. American Society of Gene and Cell Therapy (ASGCT). Washington DC, USA 6 November 2019. 8. Is Human Germline Editing Ethical? American Society for Reproductive Medicine (ASRM). Philadelphia, USA. 15 October 2019. https://vimeo.com/asrm/review/366515313/74eda0f43c 9. Human Genome Editing: Roles and Responsibilities of Fertility Clinics. American Society for Reproductive Medicine (ASRM). Philadelphia, USA. 15 October 2019. 10. Altered Inheritance. Idea: What Will the World Look Like in 2050? Chicago Ideas. Chicago, USA, 14 October, 2019. https://www.chicagoideas.com/videos/the-new-ethics-of-biogenetics-according-to- francoise-baylis 11. Made in China: Lulu and Nana. Brocher Alumni meeting. Brocher Foundation, Geneva 25-27 June 2019. 12. Panel discussion: Editing us—Merging Humans and Technology. Morals & Machines. Frauenkirche Cathedral, Dresden, 19 June 2019. 13. Human Germline Genome Editing: The Public and the Pundits. European Society for Human Genetics (ESHG) Conference. Svenska Massan Gothenburg, 17 June 2019. 14. Inexorable Moral Confusion, Revisited. Rethinking Moral Status [with Jason Scott Robert] Oxford University, Oxford, 13 June 2019. 15. The Ethics and Governance of Heritable Human Genome Editing. Frontiers in Reproduction. MBL, Woods Hole, USA 24 May 2019. 16. Ethics of Gene Editing: Now and the Future: A response to Julian Savulescu. Medicine, Technology and Ethics. Cave Hill Philosophy Symposium (ChiPS). University of the West Indies, Barbados, 24 April 2019. 17. Made in China: CRISPR Babies: Lulu and Nana. Public Policy on Science and Technology Focusing on Life and Environment. Kobe University, Japan, 25 March 2019. 18. Public Engagement with Science and Technology Assessment. Engineering Future Generations? The New Debate about Societal Governance, Public Engagement, and Human Gene Editing for Reproduction. Brocher Foundation Workshop. Geneva, Switzerland, 15 January 2019. 19. Genome Editing: State of the Art. Merry CRISPR. Finnish Bioart Society, Helsinki, Finland, 13 December 2018. 20. A Woman’s-Eye View. 14th World Congress of Bioethics, Bangalore, India, 6 December 2018 21. Breaking the Wall to Building Brains (Interlocutor with Paola Arlotta). Falling Walls Conference. Berlin, Germany, 9 November 2018. 22. Ethical Challenges of Human Germline Genome Editing. American Urological Association. Basic Sciences Symposium Part 2. San Francisco, USA, 21 May 2018 23. The Genome Engineering Revolution: CRISPR and SHEEFs. Synthetic Biology: Blurring Boundaries to Create New Realities. Me Convention. Frankfurt, Germany, 16 September 2017. https://www.youtube.com/watch?v=-X84790vZ4U&feature=youtu.be 24. Communication of Knowledge in Healthcare: Between Interests and Needs. Alpbach Health Symposium. Alpbach, Austria, 21 August 2017. 25. Clinical Research Involving Women (Including Pregnant Women). 2017 Matariki Research Ethics Workshop. Herstmonceux Castle, England, 15 August 2017. 26. Public Perceptions of Science and Factors that May Erode Trust. Ethics of CRISPR technology. Berkeley, USA, 19 June 2017 [follow-up to previous meeting January 26-29 2017]. 27. Human Gene Editing: The Dawn, the Zenith and the Dusk. EuroMedLab. Athens, Greece, 13 June 2017. 28. Debate: The Ethics of Gene Editing. EuroMedLab. Athens, Greece, 13 June 2017.

Françoise BAYLIS (23 March 2020) Page 28 of 53 29. Ethics and Embryo Research; Braving the Human Genome: Who Decides about What? Frontiers in Reproduction. MBL, Woods Hole, USA 23 May 2017. 30. Braving the Human Genome: Who Decides about What? A Century of Engineering Life: Cells and Organisms. MBL-ASU History of Biology, Woods Hole, USA 23 May 2017. 31. The Governance of Human Germline Gene Editing: Who Decides About What? Editorial Aspirations: Human Integrity and the Frontiers of Biology, Harvard University, Boston, USA, 27 April 2017. 32. Identity: Memory, Belonging, Recognition. San Diego State University, San Diego, USA, 25 January 2017. 33. Breaking the Wall between Gene Science and Ethics: How Philosophy Can Provide Frameworks for a Global Biotech Revolution. Falling Walls Conference. Berlin, Germany, 9 November 2016. http://falling-walls.com/videos/Françoise-Baylis-10662; https://vimeo.com/193507280 34. Do-it-Together Ethics. Public Participation in Bio-Innovation. Museum für Naturkunde. Berlin, Germany, 7 November 2016. 35. States of Mind & Relational Identity. 2016 NTC Kavli Futures Symposium “Ethical Foundations of Novel Neurotechnologies: Identity, Agency and Normality.” Columbia University, New York, USA. 10 September 2016. 36. Ethics and Embryo Research; Ethics and Gene Editing. Frontiers in Reproduction. Woods Hole, USA, 27 May 2016. 37. “I Am Who I Am”; “She Is Who She Is”: When Illness and Technology Disrupt the Narrative Flow. Stimulating the Self: Neural Technologies, Identity and Agency. University of Washington, Seattle, USA, 22 April 2016. 38. The Ethical Dimensions of New Human Gene Editing Technology. AAAS Annual Meeting. Washington D.C. USA, 12 February 2016. 39. Gamete Donation. Inter-country Medically Assisted Reproduction: Conceiving a Human Rights Ethic of Care. Brocher Foundation Workshop. Geneva, Switzerland, 18-21 January 2016. 40. Interrogating Equity. International Summit on Human Gene Editing. Washington, DC, USA, 3 December 2015. 41. /ˈɡadˌflī/. Whistleblowers and the Exposure of Clinical Research Misconduct. Brocher Foundation Workshop. Geneva, Switzerland, 18 November 2015. 42. Impact Ethics: Making A Difference. Global Health Ethics, Department of Knowledge, Ethics and Research. WHO. Geneva, Switzerland, 26 October 2015. 43. Is There a Compelling Need for Mitochondrial Replacement? Invitational symposium Me Medicine vs. We Medicine: Personalised Medicine, Individual Choice and the Common Good. Amsterdam, The Netherlands, 9-10 September 2015. 44. Smart Women Freeze: So Say … Brocher Summer Academy on Ethical, Legal and Social Issues (ELSI) in Assisted Reproductive Technologies (ART). Geneva, Switzerland. 1-5 June 2015. 45. Ethics Primer and Embryo Research. Frontiers in Reproduction. Woods Hole, USA. 29 May 2015. 46. Baby-Making: The Harms of Contractual Pregnancy. Ken Mason Lecture. University of Edinburgh. Edinburgh, Scotland, 12 March 2015. https://www.youtube.com/watch?v=tIkQHWEQTrk 47. International Forum on Intercountry Adoption & Global Surrogacy. Commentator for one of the sessions on Global Surrogacy Practices. The Hague, Netherlands, 11-13 August 2014. 48. Are There Heroes in Bioethics? Courage and Compassion in Healthcare. Arizona Bioethics Network 4th Annual Conference. Scottsdale, Arizona, USA, 11 April 2014. 49. Impact Ethics. MA AEP, Arizona State University, Tempe, Arizona, USA, 9 April 2014. 50. Against Mitochondrial Replacement. American Philosophical Association Central Division, One Hundred Eleventh Annual Meeting, Committee on Philosophy and Medicine: Ethics in Reproductive Technology, Chicago, USA, 1 March 2014. 51. Deep Brain Stimulation, Personal Identity, Neuroenhancement. 2013 Neuroethics International Conference ‘Neuroethics in Context: East Meets West’. Seoul, Korea, 11 January 2013. 52. The Whys and Ways of Encouraging More Studies Related to Vaccination in Pregnancy. Maternal Immunization: Challenges and Opportunities. Fondation Merieux, Veyrier-du-Lac, France, 26 September 2012. 53. Embryonic Ethics. Genetics Otago Symposium. Dunedin, New Zealand, 5 December 2011. 54. Is DBS for Parkinson’s Disease a Threat to Personal Identity? Centre for Law and Policy in Emerging Technologies. Dunedin, New Zealand, 21 November 2011.

Françoise BAYLIS (23 March 2020) Page 29 of 53 55. Conscience, Due Diligence, Undue Deference. The Spark of Conscience Inflames Debate: Conflicts of Conscience in Health Care. Santa Clara University, San Jose, USA, 3 November 2011. 56. The Science, Ethics and Politics of hESC research. National Workshop on regulations and bioethics of stem cell applications. Organized jointly by the Jordan National Committee for Ethics of Science and Technology (JNCEST), the University of Jordan and UNESCO Cairo Office. Amman, Jordan, 5-6 October 2011. 57. Ethics and AHR in Canada: State of Play. Ethics Committee on Assisted Reproductive Technology (ECART), Wellington, New Zealand, 29 September 2011. 58. “I Am Who I Am”: On the Perceived Threats to Personal Identity from Deep Brain Stimulation. Department of Philosophy. Canterbury University, Christchurch, New Zealand, 6 September 2011. 59. The Perceived Threat to Personal Identity from Deep Brain Stimulation. Bioethics Centre, University of Otago, Dunedin, New Zealand, 8 August 2011. 60. Pregnant Women and Research: Trials and Tribulations. Bioethics Centre, University of Otago, Dunedin, New Zealand, 28 March 2011. 61. First “First-in-Human Trials” With Neural Stem Cells. Bioethics and Experimental Neuroscience. London, U.K., 7 May 2010. 62. Deep Brain Stimulation and Relational Identity. LABTEC, Kings’ College London, U.K. 5 May 2010. 63. Policy Challenges Ahead. Beyond Pattison: Challenges to Stem Cell Translation and Policy. London, U.K., 7-8 May 2009. 64. Neurotechnological Enhancement. Pimp Your Brain! Theater Freiburg, Freiburg, Germany, 16-19 April 2009. 65. Slippery Slopes and Cytoplasmic Hybrid Embryo Research, PEALS Symposium, Durham Castle, United Kingdom, April 2008. 66. Plenty cheap: Animal Eggs for hESC Research. From Standards to Concerted Programs of Collective Action: The Standardization Process of Medical Practices. European Science Foundation Exploratory Workshop. René Descartes University Paris V, Paris, France, 5-7 December 2007. 67. Creating Humanesque Embryos. International Conference on the “Healthy” Embryo. University of Western Ontario, London, Ontario, November 2007. 68. On the Path to Regenerative Medicine: Stem Cell Research and Crossing Species Boundaries. Facts at the Frontier: Crossing Boundaries between Natural and Social, Animal and Human. London School of Economics. London, UK, April 2007. 69. Dancing with the Porcupine: Conflict of Interest in Research Involving Humans, Responsible Conduct of Research Luncheon, Arizona State University, Phoenix, Arizona, February 2007. 70. Promises and Perils of Embryonic Stem Cell Research: Advancing the Ethics. Lincoln Center for Applied Ethics, Arizona State University, Phoenix, Arizona, February 2007. 71. Feminist Consultation. 6th International Congress on Feminist Approaches to Bioethics, Beijing China, August 2006 (with S. Dodds). 72. Ethics, Embryos and the Art of Finesse. International Society for Stem Cell Research, Toronto, Ontario, July 2006. 73. Chimera Research and Stem Cell Therapies for Human Neurodegenerative Disorders, Fletcher Allen Medical Center, University of Vermont Medical School and College of Nursing and Health Science. Neuroscience Center of Biomedical Research Excellence (COBRE), telemedicine, May 2006. 74. Global Norms in Bioethics: A Response to Harris. A Symposium on Global Bioethics, Dartmouth College, Hanover, NH, October 2005. 75. Do Bioethicists Have Professional Obligations? American Society for Bioethics and Humanities, Spring Meeting: The Ethics of Bioethics Albany, NY, April 2005. 76. Human Embryonic Stem Cell Research: Policy and Politics, The Social and Cultural Implications of New Biomedical Technologies, University of Missouri-Columbia, Missouri, March 2005. 77. Bioethics & You: Where Are We Going With Gene Technology, Stem Cells And Cloning? Public Forum. Sydney, Australia, November 2004. 78. Embryonic Stem Cell Research and Policy-Making in the Public Interest, University of Otago, Dunedin, New Zealand, November 2004. 79. Embryonic Stem Cell Research and Policy-Making: In the Public Interest. Gordon Research Conference on Science and Technology Policy: Who Wins, Who Loses, and Who Cares? Big Sky Resort, Montana, August 2004.

Françoise BAYLIS (23 March 2020) Page 30 of 53 80. The Ethics of Giving and Selling Eggs and Embryos for Therapy or Research. 17th International Conference for Nurses and Support Personnel in Reproductive Medicine, San Diego, May 2004. 81. Human Stem Cell Research: Our Ethics are Embryonic. University of Missouri-Kansas City, Kansas, Missouri, March 2003. 82. IRBs: Protecting Subjects from Harm in Research. National Ethics Conference on National Bioethics Advisory Commission Report: ‘Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity’ Baltimore, Maryland, November 1998. 83. Making Ethical Decisions within a Cultural Context. The Ohio State University, Medical Humanities Program, Columbus, Ohio, February 1996. 84. How the Health Care System Shapes the Ethical Issues. Michigan Ethics Resource Network, Kalamazoo, Michigan, May 1993. 85. The Future of Bioethics Consultation. Society for Bioethics Consultation, Chicago, Illinois, September 1992. 86. Ethical Implications of Limited Resources in Healthcare. Wisconsin Ethics Committee Network, Summer Meeting, King, Wisconsin, June 1990.

REFEREED PRESENTATIONS (NATIONAL) (28) 1. The Roles and Responsibilities of Scholars in Creating Public Debate: Challenging Intuitive Ethical Considerations. Philosophy in and for Society: Developing Best Practices for Engagement. The Canadian Philosophical Association/ L’Association canadienne de philosophie. Université du Québec à Montréal, Montreal, Quebec. 5 June 2018. 2. Vulnerability and Identity. 28th Annual Meeting of the Canadian Bioethics Society. Montreal, Quebec, 26 May 2017. 3. Patients’ Decision-making Regarding Disposition of their Surplus Frozen Embryos. Canadian Fertility and Andrology Society. Québec City, Quebec, (with Janet Takefman, Marie-Claude Léveillé, Arthur Leader and Vanessa Gruben), 13, September 2014. 4. Family Making: Contemporary Ethical Challenges (Book Panel Joint Session of ACPA—CSWIP) Congress 2014. Brock University. Ste Catherine, Ontario, (with Carolyn McLeod, Amy Mullin, Alice MacLachlan, Sarah Hannan, and Vida Panitch), 28, May 2014. 5. ‘What is Conscience?’ and ‘Why Should the State Value Conscience-based Action?’ Annual Meeting of the Atlantic Region Philosopher’s Association, Halifax, Nova Scotia, 5, October 2013. 6. Eggs and Embryos for Research. 23rd Annual Meeting of the Canadian Bioethics Society. Montreal, Quebec, 31 May 2012. 7. Personal Identity: The Promise and Threat of Deep Brain Stimulation. Brain Matters2. Montreal, Quebec, 26 May 2011. 8. A Relational Ethic for Public Health. Canadian Pandemic Preparedness Meeting: Outcomes, Impacts and Lessons Learned, Montreal, Quebec, 12-13 November 2010. 9. Public Health Renewal: The Need for a New Ethic. Canadian Public Health Association Annual Meeting. Halifax, Nova Scotia. June 2008 (with N.P. Kenny, S. Sherwin). 10. Neuroenhancement for Sustainable Well-Being. Workshop. 19th Annual Meeting of the Canadian Bioethics Society. Toronto, Ontario, May 2007 (with W. Glannon, E. Racine & J. S. Robert). 11. The Ethics of Asking Patients to Donate Fresh Embryos to Stem Cell Research. Panel on Reproductive Autonomy. Canadian Philosophical Association Annual Meeting 2006, York University, Toronto, Ontario, May 2006 (with C. McLeod). 12. La recherche sur les chimères et les traitements aux cellules souches pour les maladies neurodégénératives humaines. La neuroéthique. Une science du XXIe sciècle. Le savoir: trame de la modernité 74e Congrès de l’ACFAS. McGill, Montréal, Québec, May 2006. 13. All the Way to the Bank: Ethical Policy Options for Stem Cell Resources. 17th Annual Meeting of the Canadian Bioethics Society, Halifax, Nova Scotia, October 2005 (with M. Giacomini and J. S. Robert). 14. Narrative Evaluation of Ethical Dilemmas in the Clinical Clerkship: Fourth Year Bioethics Assignment. CAME/ACMC, Halifax, Nova Scotia, April 2004 (with J. Nisker). 15. Human Embryonic Stem Cell Research: Comments on the NBAC Report. 13th Annual Meeting of the Canadian Bioethics Society, Québec City, Québec, October 2000. 16. Respect for Children: Meaningful Involvement in Biomedical and Health Research. 11th Annual meeting of the Canadian Bioethics Society, Toronto, Ontario, October 1998 (with N. Kenny).

Françoise BAYLIS (23 March 2020) Page 31 of 53 17. Women and Health Research: New Canadian Research Guidelines. 11th Annual Meeting of the Canadian Bioethics Society, Toronto, Ontario, October 1998 (with J. Downie & S. Sherwin). 18. Ethics and the Peer Review Process: The “Suppression” of Controversial, Innovative Scholarship in Bioethics.10th Annual Meeting of the Canadian Bioethics Society, Halifax, Nova Scotia, October 1997 (with C. Weijer & K. Morgan). 19. Power-with, Not Power-over: Families, Ethics Consultants and Decision-making in Clinical Ethics Consultation. 9th Annual Meeting of the Canadian Bioethics Society, Montréal, Québec, October 1996. 20. A Feminist Analysis of Women and Research. 8th Annual meeting of the Canadian Bioethics Society, Vancouver, B. C., November 1995 (with J. Downie). 21. Child Abuse through the Lenses of Gender and Culture. 7th Annual Meeting of the Canadian Bioethics Society, Ottawa, Ontario, November 1994 (with J. Downie). 22. Primum Non Nocere: Patients, Professionals and Policies in Canadian Paediatric Institutions. Canadian Bioethics Society, Annual Meeting, Montréal, Québec, November 1993. 23. The Profile of the Health Care Ethics Consultant. 5th Annual Meeting of the Canadian Bioethics Society, Toronto, Ontario, October 1992. 24. Research: A Way of Caring for Children. 4th Annual Meeting of the Canadian Bioethics Society, Annual Meeting, Hamilton, Ontario, November 1991 (with J. Downie). 25. Protective Privilege and Public Peril. Moral Philosophy in the Public Domain, Vancouver, British Columbia, June 1990. 26. Death and Dying in Children's Literature. King's College, Death and Bereavement: Creative Strategies, London, Ontario, May 1990 (with J. Downie). 27. The Ethics of Research on Spare 'IVF' Human Embryos. 2nd Annual meeting of the Canadian Bioethics Society, Calgary, Alberta, November 1989. 28. Teaching Ethics to Medical Students in the Classroom Setting. 1st Annual Meeting of the Canadian Bioethics Society, Toronto, Ontario, November 1988.

INVITED PRESENTATIONS (NATIONAL) (61) 1. Heritable Human Genome Editing: Ethics & Governance. Women in Science and Engineering, Toronto, Ontario, 26 January 2020. 2. The Roles and Responsibilities of Scholars in Creating Public Debate: Challenging Intuitive Ethical Considerations. Congress 2018: Big Thinking Lecture Series. Regina, Saskatchewan. 31 May 2018. 3. Why Feminist Philosophy Matters to the Health of Canadians. SueFest. Halifax, Nova Scotia, 26 May 2018. 4. Rethinking the Principles. Judicial Ethics Seminar: Ethics in the Age of Disruption. Quebec City, Quebec, 16 May 2018. 5. Where to From Here? A Canadian Strategy for AHR. Path Forward for the Assisted Human Reproduction Act, Best Brains Exchange, Ottawa, 13 March 2018. 6. Activism and the Hallowed Halls of Academia. Feminism, Philosophy, and Engaging the Public: Theory, Policy and Practice. Canadian Society for Women in Philosophy, London, Ontario. 27 October 2017. 7. To Speak Out, to Stand Up and to Always do so With Integrity. Lifetime Achievement Award. 28th Annual Meeting of the Canadian Bioethics Society. Montreal Quebec. 24 May 2017. 8. Canada Gets a Failing Grade on Inclusion of Pregnant Women in Clinical Research. CAREB-ACCER 2017 National Conference and Annual General Meeting. Halifax, Nova Scotia, 29 April 2017. 9. Human Gene Editing: Insights from Slow Science. Gairdner Symposium: Gene Editing: from Bacterial Immunity to Global Impact. Toronto, Ontario. 28 October 2016. https://www.youtube.com/watch?v=zuKaFmASXoI; https://www.youtube.com/watch?v=hC4vrcch1H8 10. Women, Wisdom, and Wonder: The 3Ws of CRISPR Science and Ethics. Speaking Her Mind: Canadian Women and Public Presence. Calgary, Alberta. 21 October 2016. 11. Conversations with my Mother. The Walrus Talks: The Art of Conversation. Calgary, Alberta. 20 October 2016. https://www.youtube.com/watch?v=4W3lPUXIi-0 12. The Meaning of Ethics. Judicial Ethics Seminar. Vancouver, B.C. 11 May 2016. 13. My Academic Mission: To Make the Powerful Care. Spring CAUT Council Meeting. Ottawa, Ontario, 30 April 2016. https://www.cautbulletin.ca/en_article.asp?ArticleID=4207

Françoise BAYLIS (23 March 2020) Page 32 of 53 14. “I’m Still a Person” 13th Annual Geriatric Services Conference, Shaping the Future. Tapestry Foundation. Vancouver, B.C., 29 April 2016. https://youtu.be/NYasXd6-9eI 15. AHR in Canada: The Times They Are a Changin’. Donor Conception: Lessons for clinicians, families, policy makers and researchers. Montréal, Québec, 20 June 2013. 16. hESC Research for Spinal Cord Injury: Good Ethics = Good Science. The Spinal Cord: Functional Restoration and Repair. 2013 Canadian Spinal Cord Conference. Halifax. Nova Scotia, 23 April 2013. 17. Recommended but Unfunded Vaccines: An Ethics Perspective. Workshop on Recommended but Unfunded Vaccines: What Can Be Done to Improve Their Use? Ottawa, Ontario, 2 November 2012. 18. Contemporary Ethical Challenges in Neuromodulation Cases. 6th Annual Meeting of the Canadian Neuromodulation Society. The Briars, Ontario, 15 June 2012. 19. Ethical Oversight of AHR in Canada: State of Play. Reference re: Assisted Human Reproduction Act: 20. Implications of the Supreme Court’s Decision. Health Law Group, Faculty of Law & David Asper Centre for Constitutional Rights. University of Toronto, Toronto, 5 November 2011. 21. Ethical Approaches to Immunization. Immunization: A Global Challenge for the 21st Century. 9th Canadian Immunization Conference, Québec, Québec, 6 December 2010. 22. Ethical Aspects of Cross-Border Reproductive Care. CFAS 2010 Annual Meeting, Vancouver, B.C., 1 October 2010. 23. Ethics and AHR in Canada: Current State. CFAS 2010 Annual Meeting, Vancouver, B.C., 30 September 2010. 24. Research Involving Pregnant Women: Trials and Tribulations. CFAS-IHDCYH Symposium for Investigators and Trainees in Reproductive Health Research, Vancouver, B.C., 29 September 2010. 25. From H1N1 to Health Equity: Knowledge Exchange, Risk Communications and Decision-making. Public Health in Canada: Shaping the Future Together, Toronto, Ontario, 14 June 2010. 26. Deep Brain Stimulation for Neuroenhancement: Ethical and Social Implications. Fourth JEMH Conference on Ethics in Mental Health. Peterborough, Ontario, 14 May 2010. 27. A Relational Ethics for Public Health. CIHR IPPH Population Health Ethics Journal Club (audio conference), 8 March 2010. 28. Unique Challenges in Providing Care to Adolescents: Ethical Considerations. Society of Obstetricians and Gynecologists 65th Annual Clinical Meeting, Halifax, Nova Scotia, 18 June 2009. 29. Proposed Revisions to the Draft 2nd Editions of the TCPS. (Panel member) Just Evidence? 20th Annual Meeting of the Canadian Bioethics Society, Hamilton, Ontario, 12 June 2009. 30. Reflections and Directions in Education and Training. Health Policy Ethics: Cultivating a Growing Field in Canada. (Panel member). Pre-conference meeting. 20th Annual Meeting of the Canadian Bioethics Society, Hamilton, Ontario, 11 June 2009. 31. Gene-Environment Interaction: The Gulf between What We Know and What We Do. Royal Society of Canada Annual Symposium – Social Sciences Facing Modern Genetics Challenges: Changing Boundaries between Gene Expressions, Behaviour and the Social Fabric. Edmonton, Alberta, November 2007. 32. Ceasarean ‘On Demand’ / Ceasarean ‘On Request’. Society of Obstetricians and Gynecologists 63rd Annual Clinical Meeting, Ottawa, Ontario, June 2007. 33. On the Path to Regenerative Medicine: Stem Cell Research and the Ethics of Crossing Species Boundaries. Form and Function in Ocular Disease, Halifax, Nova Scotia, October 2006. 34. Neuroethics: What is it and What Comes Next? JEMH Conference on Ethics in Mental Health – The Guises of Power: Subtle, Perceived, Insidious, Toronto, Ontario, May 2006. www.jemh.ca 35. Ethics, Embryos and Stem Cell Research. Pre-Conference Workshop 17th Annual Meeting of the Canadian Bioethics Society, Halifax, Nova Scotia, October 2005. 36. Future Directions in Health Research: “Of means and ends” Leaders’ Forum for Health Research in Canada, Ottawa, Ontario, September 2004. 37. Oocytes, Embryos and Stem Cells as Property or Commodities? 2nd Canadian Developmental Biology Symposium, Banff, Alberta, April 2004. 38. Human Stem Cell Research and the Politics of Cloning. Stem Cell Network 2nd Annual General Meeting, Vancouver, B.C., September 2003. 39. Embryonic Stem Cell Research: An Uncertain Future. Stem Cell Network 1st Annual General Meeting, Toronto, Ontario, September 2002. 40. The Ethics of Deriving Human Stem Cells. Society of Obstetricians and Gynecologists 58th Annual Clinical Meeting, Winnipeg, Manitoba, 25 June 2002.

Françoise BAYLIS (23 March 2020) Page 33 of 53 41. Ethical Implications of Gene Therapy. CFBS 45th Annual Meeting, Montreal, Quebec, June 2002. 42. The Ethics of Deriving Human Stem Cells. Society of Obstetricians and Gynecologists 12th West/Central CME Programme, Banff, Alberta, February 2002. 43. Pushing the Edge of the Envelope: Pluripotent Stem Cell Research. Annual Meeting, Canadian College of Medical Geneticists and Canadian Association of Genetic Counsellors, Halifax, Nova Scotia, December 2001. 44. A Reflection on the ‘Place’ of Bioethics. 13th Annual Meeting of the Canadian Bioethics Society, Winnipeg, Manitoba, October 2001. www.bioethics.ca/english/am/baylis20001/cbs2001b2.ppt 45. What Do You Need to Know? Knowledge, Skills and Abilities. 13th Annual Meeting of the Canadian Bioethics Society, Winnipeg, Manitoba, October 2001. 46. Ethical Challenges for Research in the New Genetics. After Dinner Address. CIHR Health Services Workshop, Toronto, Ontario, September 2001. 47. Ethical Challenges for Research in the New Genetics. Keynote Address. Ethical Challenges for Research in the New Genetics. Winnipeg, Manitoba, June 2001. 48. Values: From Paper to Practice. Keynote Address. Quest for Quality in Acute Care. Health Canada. Halifax, Nova Scotia, June 2001. 49. Ethics and Reproduction: There is Cloning, and Then There is Cloning! CESAF Women’s Health and Diversity Centre of Excellence for Women’s Health, National Conference, Montréal, Québec, April 2001. 50. The Inevitability of Genetic Enhancement Technologies. The Canadian Charter of Rights and Freedoms: Twenty Years Later Canadian Bar Association, National Conference, Ottawa, Ontario, April 2001. 51. Health Care Ethics Consultation: A Comparison of Canadian and American Standards. Pre- conference Workshop on Healthcare Ethics Committees: Meeting our Communities’ Diverse Needs. 10th Annual Meeting of the Canadian Bioethics Society, Toronto, Ontario, October 1998. 52. Ethics Consultation Resources: Where to Go For Help! Ethics in the Boardroom and the Administrative Office, Canadian College of Health Service Executives and Catholic Health Association of Canada, Toronto, Ontario, December 1997. 53. Functions of Ethics Committees -- Pre-conference Workshop on Ethics Committees: Developments and Challenges. 9th Annual Meeting of the Canadian Bioethics Society, Halifax, Nova Scotia, October 1997. 54. Inclusion/Exclusion of Vulnerable Persons in Research. Royal College of Physicians and Surgeons of Canada, Halifax, Nova Scotia, September 1996. 55. Ethicist's Perspective on Research Involving Children. National Council on Bioethics in Human Research, Ethics of Research Involving Children, Ottawa, Ontario, December 1992. 56. Les testaments biologiques. The Canadian Bar Association, Annual Meeting, Halifax, Nova Scotia, August 1992. 57. Une enquête canadienne faite sur la professionnalisation du bioéthicien. Session international d'été, Québec City, Québec, August 1992. 58. The Integration of Biomedical Ethics into the Undergraduate and Postgraduate Curriculum. Association of Professors of Obstetrics and Gynaecology, Annual Meeting, Toronto, Ontario, December 1991. 59. Infertility and Informed Choice. Canadian Fertility and Andrology Society, Annual Meeting, Québec City, Québec, September 1991. 60. Health Care Ethics Consultation: The Practice. Canadian Society for the Study of Practical Ethics, Kingston, Ontario, May 1991. 61. The New Reproductive Technologies: Choice and Consent. Society of Obstetricians and Gynaecologists of Canada, Annual Meeting, Halifax, Nova Scotia, June 1990.

INVITED PRESENTATIONS (OTHER) (137) 1. Altered Inheritance: CRISPR and the Ethics of Human Genome Editing. Rogers Insurance, Calgary, Alberta, 12 February, 2020. 2. Altered Inheritance: CRISPR and the Ethics of Human Genome Editing. Montreal, Quebec, McGill University, 23 January 2020. 3. Human Germline Genome Editing: Scientists, Science Policy and Politics. Centre for Genomics Enhanced Medicine. Dalhousie University, Halifax, Nova Scotia, 9 October 2019.

Françoise BAYLIS (23 March 2020) Page 34 of 53 4. Governance and Oversight of Heritable Human Genome Editing. Department of Pediatrics, Division of Medical Genetics, Dalhousie University, Halifax, Nova Scotia, 11 September 2019. 5. Data Mining the Deceased, Halifax Central Library, Halifax, Nova Scotia, 3 February 2019. 6. Be it Resolved: The Prohibition on Payment for Surrogacy and Gametes in Canada Should be Repealed. Regulating Creation and The Assisted Human Reproduction Act, University of Toronto, Faculty of Law and Institute of Health Policy, Management and Evaluation, Toronto, Ontario, 22 November 2018. 7. Ancestry Tracing: Can Genetics Tell You Who You Are? Café Scientifique. The Nook Espresso Bar & Lounge, Halifax, Nova Scotia, 29 October 2018. 8. The Ethics of Bio-Data & Genetic Genealogy. Archives of Ontario, Toronto, Ontario, 21 September 2018. https://www.youtube.com/watch?v=aneNIHREKnY 9. Impact Ethics. Tzavta Cultural Salon and Dinner. Calgary, Alberta, 29 May 2018. 10. Editing the Human Genome: The Ethics of Moulding our Future. Panel discussion. Rotman Institute, London, Ontario, 14 March 2018. https://www.youtube.com/watch?v=V9ucpTmfrbQ 11. The Ethics of Human Gene Editing: Where Should We Draw the Line? Ethics in the 21st Century: Body, Mind, Spirit: An Interdisciplinary Conference. Memorial University, St. John’s, Newfoundland, 29 November 2017. 12. Activism and the Hallowed Halls of Academia. Department of Philosophy, Dalhousie University, Halifax, Nova Scotia, 17 November 2017 13. Braving the Human Genome: Who Decides About What? The Genome Engineering Revolution: CRISPR and SynBio, Genome BC Genomics Forum, Vancouver, BC, 25 May 2017. 14. CRISPR Panel Discussion with Dr. Feng Zhang. Dalhousie University, Nova Scotia, 30 March 2017. 15. Conversations with my Mother: Alzheimer’s Disease and Personal Identity. St-Boniface Hospital, Winnipeg, Manitoba, 10 March 2017. 16. Human Germline Genome Editing: The Ethics of Engineering our Cells, Ourselves. University of Manitoba, Winnipeg, Manitoba, 9 March 2017. 17. Conversations with my Mother. Alzheimer’s Awareness Month. Halifax, Nova Scotia, 23 January 2017. 18. Empathy. Empathy: A Blessing or a Curse? An Evenspeak Series. University of King’s College Chapel, Halifax, Nova Scotia, 18 January 2017. 19. Human Gene Editing: Insights from Slow Science. Symposium on the Science of Gene Editing and Its Social, Cultural, Economic and Ethical Implications. RSC-Atlantic. Halifax, Nova Scotia, 28 November 2016. 20. Understanding Policy Options to Reduce Risk and Mitigate Harms Associated with Expanding Government Provided Online Gambling in Nova Scotia. CIHR Best Brains Exchange. Halifax, Nova Scotia, 30 May 2016. 21. Pay-for-Plasma. Panel discussion with the Council of Canadians Atlantic Office. Halifax Central Library, Halifax, Nova Scotia, 25 April 2016. 22. Legal Schmegal: What’s a Little Cash between Friends? Assisted Reproduction: Navigating the Criminalization of Commercial Surrogacy and Reacting to Unexpected Situations. McGill University, Montreal, Quebec, 6 February 2016. 23. A Relational View of Conscience and Physician Conscientious Action. Humanities Research Group. 2014-2015 Distinguished Speaker Series. Windsor University. Windsor, Ontario, 6 March 2015. 24. Ladies, Don’t Freeze Your Eggs!! Humanities Research Group. 2014-2015 Distinguished Speaker Series. Windsor University. Windsor, Ontario, 5 March 2015. 25. Ladies, Don’t Freeze Your Eggs!! Philosophy in Practice. 2015 Ryerson Graduate Philosophy Conference. Toronto, Ontario, 27 February 2015. 26. Sexualized Violence on Our Campuses Panel discussion for Canadian Centre for Ethics in Public Affairs, 8 January, 2015. 27. Mon bébé sur Mesure? Choisir nos Enfants Grâce aux Tests Génétiques. Café Scientifique. Panel member. Montreal, Quebec, 21 May 2014. 28. Controverses Actuelles En Éthique De La Procreation. Les Séminaires de l’IRSPUM. Montreal, Quebec, 21 May 2014. 29. Should Your Tax Dollars Pay for IVF? Café Scientifique. Panel member. Halifax, Nova Scotia, 13 May 2014.

Françoise BAYLIS (23 March 2020) Page 35 of 53 30. Withdrawing Life Sustaining Care. Café Scientifique. Panel member. Halifax, Nova Scotia, 24 March 2014. 31. Ethics & Deep Brain Stimulation. S.C.A.N.S, Halifax, Nova Scotia, 15 October 2013. 32. Pregnant Women and Health Research: An Ethical Imperative. Queen’s University, Kingston, Ontario, 7 May 2013. 33. Immunology: Arthritis, Transplants and Vaccines. Café Scientifique. Panel member. Halifax, Nova Scotia, 29 April, 2013. 34. Legal Schmegal: Who Cares What the AHR Law Says? ARTs and Canadian Public Policy Today: A Feminist Conversation, Toronto, Ontario, 26 April 2013. 35. Ethics & Deep Brain Stimulation. Athenaeum Society, Ocean Swells Community Centre, Nova Scotia, 21 April 2013. 36. Missed Trials: Research Involving Pregnant Women. People’s Health Matters, Memorial University, St. John’s, Newfoundland, 8 March 2013. 37. Social Responsibility of Gaming. CIHR Best Brains Exchange. Halifax, Nova Scotia, 24 October, 2012. 38. Ethically Sound Research Involving Pregnant Women. Bioethics in the City, Halifax, Nova Scotia, 30 August 2012. 39. Research Involving Pregnant Women: An Ethical Imperative. McGill University Health Centre, Montréal, Québec, 4 May 2012. 40. Research Ethics: The Obligation to Include Pregnant Women in Research. Science in the City, Bourns Lecture in Bioethics, McMaster University, Hamilton, Ontario, 14 February 2012. https://www.youtube.com/watch?v=XTSRzf60Hlc 41. AHR Governance. New Approaches to Assisted Human Reproduction in Canada after the Supreme Court of Canada reference: A Research Roundtable. University of Manitoba Centre for Human Rights Research/Canadian Journal of Women and the Law and the University of Manitoba Legal Research Institute, Winnipeg, 2-4 February 2012. 42. First ‘First-in-Human’ Trials with Neural Stem Cell. Neuroethics mini-symposium, Dalhousie University, Halifax, Nova Scotia, 16 June 2010. 43. The Self in situ: A Relational Account of Personal Identity. Department of Philosophy, Dalhousie University, Halifax, Nova Scotia, 5 March 2010. 44. Pregnant Women and the H1N1 Vaccine. Health Law Institute Seminar Series, Halifax, Nova Scotia, Dalhousie University, 5 March 2010. 45. Just in Time: Health Research? The Implications of Pharmaceutical Industry Influence from the Laboratory to the Marketplace, Halifax, Nova Scotia, 15 February 2010. https://www.youtube.com/watch?v=VrEB-gd8lDs 46. The Disappearing Male (film and panel discussion) Joint Institute of Gender and Health and the Institute of Population and Public Health Public Event. Halifax, Nova Scotia, September 16, 2009. 47. Sex, Lies and Vaccination: HPV – the big facts. 7th Annual Paul Harding Research Awards Day. Earl Plunkett/Wyeth Lecture. London, Ontario, 13 May 2009. 48. Ethical issues in the translation of cell therapies from the lab to the human. Spinal Cord Group Meeting, Dalhousie University, Halifax, Nova Scotia, 28 April 2009. 49. Sex, Lies and Vaccination: HPV – the big facts. Canadian Centre for Vaccinology-Halifax, Annual Meeting and Symposium, Halifax, Nova Scotia, February 2009. 50. Plenty Cheap: Animal eggs for stem cell research. Nova Scotia Agricultural College, Truro, Nova Scotia, 11 September 2008. 51. Ethics and Human Embryonic Stem Cell Research. École acadienne de Truro, Truro, Nova Scotia, 11 September 2008. 52. Stem Cell Research: The Buying and Selling of Human Eggs. Novel Tech Ethics & Discovery Centre, Halifax, Nova Scotia, September 2007. 53. Drugging for Success: Students, Smart Drugs & Schools. Novel Tech Ethics & Discovery Centre, Halifax, Nova Scotia, March 2007. (with D. Phillips, D. Weaver & C. Poulin) 54. Whose Business is it Anyway? Science and the Corporate World. Trust in Science, Canadian Centre for Ethics in Public Affairs, University of King’s College and Dalhousie University, Halifax, Nova Scotia, March 2007. (with F. Doolittle, S. Mithani & A. Edwards) https://www.youtube.com/watch?v=zWGkHGKPAHE

Françoise BAYLIS (23 March 2020) Page 36 of 53 55. Chimera Research and Stem Cell Therapies for Human Neurodegenerative Disorders, Department of Philosophy, Dalhousie University, Halifax, Nova Scotia, November 2006. (with A. Fenton) 56. Ethical Challenges for Research in the New Genetics, Fundamentals of Research (REB Education), Capital District Health Authority, Halifax Nova Scotia, June 2006. 57. Where Are the Moral Heroes? An Ethics of Aspiration: Promoting an Authentic Ethical Climate within Health Organizations. Alberta Ethics Forum, telemedicine, May 2006. 58. Chimera Research and Stem Cell Therapies for Human Neurodegenerative Disorders, Clinical Trials Research Group, Biomedical Ethics Unit, Montréal, Québec, April 2006. 59. Ethics, Embryonic Stem Cell Research and Cloning. R.I.O.T (Realizing the Importance of Thought). Charles P. Allen High School. Halifax, Nova Scotia, March 2006. 60. The Geee! In Genome: Youth Forum. Discovery Centre, Halifax, Nova Scotia, February 2006. 61. Ethics in Practice: Responding to a Patient Complaint. 2005 Valley Spring Refresher. Wolfville, Nova Scotia, May 2005. 62. Moral Distress: Nurturing Trust. Department of Internal Medicine, University of Winnipeg, Winnipeg, Manitoba, April 2005. 63. The Ethics and Politics of Stem Cell Research. 32nd Annual Biology Symposium, York University, Toronto, Ontario, March 2005. 64. Stem Cell Research: Of Embryos and Ethics? Maritech 2004. Halifax, Nova Scotia, November 2004. 65. Genetics and Policy-Making: In the Public Interest, Apogee, Montréal, Québec, March 2004. 66. Les cellules souches: Une moralité embryonnaire? Centre de Recherche en Droit Publique CRDP, Montréal, Québec, March 2004. 67. Les cellules souches: Une moralité embryonnaire? Centre de Recherche en Ethique de l’Université de Montréal CREUM, Montréal, Québec, February 2004. 68. Creating Novel Beings. Brown Bag Research Seminar, York University, Toronto, Ontario, November 2003. 69. Our Cells/Ourselves: Ethics and Embryonic Stem Cell Research. Public Lecture. Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, November 2003. 70. Stem Cell Research in Canada: Embryos, Clones and Chimeras, Elizabeth Flagler Memorial Lecture, Sheldon Chumir Foundation for Ethics in Leadership, Calgary, Alberta, June 2003 71. Human Stem Cell Research: Embryos, Clones and Chimeras, University Hospital, London, Ontario, May 2003. 72. Crossing Species Boundaries. Department of Philosophy, University of Western Ontario, London, Ontario, May 2003. 73. The Geee! In Genome. Public Forum. Canadian Museum of Nature, Ottawa, Ontario, May 2003. 74. The Ethics of Human Stem Cell Research: Embryos, Clones and Chimeras. UCCB, Sydney, Nova Scotia, April 2003. 75. Ethics Consultation: Policies and Politics Health Law Institute Seminar Series, Halifax, Nova Scotia, Dalhousie University, March 2003 (with S. Sherwin). 76. Stem Cell Research and Human Cloning: Our Ethics are Embryonic. Kitty Lundy Memorial Lecture, York University, Toronto, Ontario, March 2003. 77. Crossing Species Boundaries. Biointerventions, Inter-generational Justice and the Re-invention of the Human. CIAR Workshop, Toronto, Ontario, March, 2003. 78. Stem Cell Research: Competing Perspectives. Human Genome Bridge Week, Faculty of Law, University of Toronto, Toronto, Ontario, February 2003. 79. Human Embryonic Stem Cell Research Capital District Health Authority REB Retreat, Halifax, Nova Scotia, January 2003. 80. Creating Alternative Families: Hindrance or Assistance? A Review of Bill C-13, the Assisted Human Reproduction Act, Nova Scotia Branch of the CBA (Sections on Health Law and Sexual Orientation), Halifax, Nova Scotia, November 2002. 81. Human Genome Symposium: Promises and Realities. Science and Society Program and Bethune College, York University, Toronto, Ontario, October 2002. 82. The Ethics of Human Embryonic Stem Cell Research. Brown Bag Lunch Series: Medical Humanities Program, Dalhousie University, Halifax, Nova Scotia, December 2001. 83. Creating ES Cells Lines: The Ethics of Derivation. Stem Cell Network. Ottawa, Ontario, November 2001.

Françoise BAYLIS (23 March 2020) Page 37 of 53 84. Pluripotent Stem Cell Research: The Ethical Issues. Robarts Institute and University Hospital, London, Ontario, November 2001. 85. Human Cloning: A Unique Enhancement Technology Brown Bag Lunch Series: Medical Humanities Program, Dalhousie University, Halifax, Nova Scotia, January 2001. 86. Genetics: Where Do We Go From Here? Technology and Change: Utopia or Dystopia? Dalhousie University, Halifax, Nova Scotia, November 2000 (with F. Doolittle). 87. Ethical or Not? The Use of Human Embryos in Stem Cell Research Health Law Institute Seminar Series, Dalhousie University, Halifax, Nova Scotia, November 2000. 88. Human Cloning: Three Mistakes and a Solution. Dr. John P. Maclean Memorial Lecture, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, April 1999. 89. Research Involving Human Embryonic Material: Ethical Considerations. McGill Biomedical Ethics Unit. Montréal, Québec, March 1999. 90. Informed Consent: Ethical Issues. Cape Breton Healthcare Complex: Workshop Series on Consent, Sydney, Nova Scotia, March 1999. 91. What is Ethics? More than Technology. Second Annual Educational Forum for Respiratory Therapists of Nova Scotia, Halifax, Nova Scotia, October 1998. 92. Reflections on the Advance Directive Exercise. Issues at the End of Life, Continuing Medical Education and Dalhousie Medical Alumni Association, Halifax, Nova Scotia, September 1998. 93. Good Clinical Practices: Balancing ICH and Tri-Council Guidelines. Enhancing the Link in Health Research, Clinical Trials Atlantic Corporation, Halifax, Nova Scotia, June 1998. 94. Informed Choice in Mental Health Practice; Confidentiality: Expectations and Limitations. Academic Day 1998, The Nova Scotia Hospital, Halifax, Nova Scotia, April 1998. 95. Women and Health Research: From Theory, to Practice, to Policy. Health Law Institute Seminar Series, Dalhousie University, Halifax, Nova Scotia, January 1998. 96. Choosing “For”, “With” or “By” Children. Day Conference. The Child’s Involvement in Health Care Decisions: Voices and Responses, Montréal, Québec, December 1997. 97. Heroes in Bioethics. A Symposium to Honour the Memory of Dr. Benjamin Freedman, Montréal, Québec, December 1997. 98. Revisiting Informed Choice: Participation in Research. Research Holiday Luncheon for the IWK- Grace Health Centre, Halifax, Nova Scotia, December 1997. 99. Informed Choice in Dentistry. Law and Ethics in Dentistry. Halifax, Nova Scotia, October, 1997. 100. Tri-Council Guidelines on Research for Human Subjects. Canadian Association of University Research Administration, Atlantic Region, Halifax, Nova Scotia, November 1996. 101. Examining Issues: Consent/Refusal; Confidentiality/Duty to Report; Resource Allocation -- An Ethical Issue. Maritime School of Social Work, Ethical Decision Making in the Helping Professions, Halifax, Nova Scotia, October 1996. 102. Pediatrics and Cross-Cultural Ethics: Child Abuse and Neglect. Confronting Culture: Ethical Controversies in Health Care, The Montreal Children’s Hospital Conference Montréal, Québec, October 1996. 103. The Elements of Informed Choice. Memorial University of Newfoundland, Workshop on Research Ethics, St. John’s, Nfld, September 1996. 104. Critical Moves. College of Physicians and Surgeons of British Columbia and the British Columbia Medical Association, Vancouver, B. C., February 1996. 105. Ethics in Clinical Medicine 'Getting Started': When is Treatment Futile? University of Manitoba, Faculty of Medicine, Ethics: Quality of Life and Decision-Making, Winnipeg, Manitoba, April 1994. 106. Have You Heard? You Need an Ethics Resource. Ontario Hospital Association, Toronto, Ontario, December 1993. 107. Ouch! You're Going to Do What to Me? Paediatric Oncology Group of Ontario, Toronto, Ontario, May 1993. 108. New Reproductive Technologies and Informed Choice. Canadian Bar Association -- Ontario chapter, Toronto, Ontario, April 1993. 109. The Ethics of Early Pre-Implantation Cell Screening (EPiCS): Policy Implications of New Reproductive Technologies. Department of Health Administration "Brown Bag Lunch" Seminar Series. University of Toronto, Ontario, March 1993. 110. The Ethics of EPiCS (Early Pre-Implantation Cell Screening). Department of Zoology, University of Toronto, Ontario, March 1993.

Françoise BAYLIS (23 March 2020) Page 38 of 53 111. Assisted Reproduction -- Philosophical and Ethical Issues. Society of Obstetricians and Gynaecologists of Toronto, Toronto, Ontario, February 1993. 112. Values and Ethical Principles in Health Care. Canadian Council of Cardiovascular Nurses, Provincial Workshop, Toronto, Ontario, December 1992. 113. The Changing Face of the Canadian Family. Toronto East General Hospital, The Changing Face of Perinatal Care, Toronto, Ontario, November 1992. 114. The Individual Practitioner and Ethical Social Health Policies. Summer Institute on Gerontology, Hamilton, Ontario, June 1992. 115. Aspects éthiques des relations 'intimes' entre thérapeutes et patients. Colloque Ethique et Psyciatrie, Montréal, Québec, April 1992. 116. Ethical Issues with Assisted Reproductive Technology. Scarborough Grace Hospital, Sixth Annual Clinical Day, Toronto, Ontario, February 1992. 117. Out of Control: Exploring Issues of New Reproductive Technologies. Legal Education and Action Fund (LEAF), Toronto chapter, Toronto, Ontario, January 1992. 118. Ethics in a Hospital Setting. Hospital Auxiliaries Association of Ontario, 81st Annual Convention, Toronto, Ontario, November 1991. 119. The Ethics of Preimplantation Genetic Screening. Southwestern Ontario Association for Clinical Chemistry, London, Ontario, May 1991. 120. Consent to Anaesthesia -- Treatment and Research. University of Toronto, 12th Annual Anaesthesia Resident's Symposium, Toronto, Ontario, May 1991. 121. Ethical Pathways through the Infertility Maze. Infertility Awareness Association of Canada Fertility Awareness: Shared Understandings, Ottawa, Ontario, May 1991. 122. The Allocation of Resources: An Ethical Perspective. Hotel Dieu Hospital, Ethical Allocation of Health Care Resources, Kingston, Ontario, April 1991. 123. Ethicist's Perspective -- How to Help Parents Make the Right Decisions. Paediatric Update, Faculty of Medicine, University of Toronto, Ontario, April 1991. 124. New Reproductive Technologies -- Wonderful or Worrisome? Ontario Medical Students' Weekend, Examining the Future, London, Ontario, February 1991. 125. The New Reproductive Technologies. Ethical Dilemmas in Reproductive Medicine, Wyeth Clinical Day, University of Toronto, Toronto, Ontario, February 1991. 126. Ethical Decision-Making. The Challenge of the 90's in Rehabilitation Ethics, Lyndhurst and Hugh MacMillan Centre, Toronto, Ontario, November 1990. 127. Ethical Issues in Home Care. Home Care Program for Metropolitan Toronto, Annual Meeting, Toronto, Ontario, October 1990. 128. The Ethics of Freezing Human Embryos. Southern Ontario Infertility Support Group Meeting, Hamilton, Ontario, June 1990. 129. Reproductive Ethics. Ontario Medical Secretaries, Annual Convention, North Bay, Ontario, May 1990. 130. Equitable Health Care for the Elderly. Health Care Ethics 2001, Westminster Institute for Ethics and Human Values, London, Ontario, May 1990. 131. Conflict of Interest in Physiotherapy. Ontario Board of Directors of Physiotherapy Open Forum, Toronto, Ontario, April 1990. 132. Suggestions from Britain: A Critical Analysis of The Pond Report. Westminster Institute for Ethics and Human Values, Postgraduate Medical Ethics Education, London, Ontario, March 1990. 133. Ethics and the New Reproductive Technologies. McMaster University, Women and Technology, Hamilton, Ontario, March 1990. 134. The Revolution in Reproductive Technology and the Questions it Raises. York University, Playing With Life: Scientific and Ethical Challenges for the 90s, Toronto, Ontario, February 1990. 135. The Use and Abuse of Case Studies. Westminster Institute for Ethics and Human Values, Undergraduate Medical Ethics Education, London, Ontario, March 1989. 136. Embryo Research: Pathways to a 'Brave New World'. University of Western Ontario, Student Centre for Public Issues and Westminster Institute for Ethics and Human Values, Reproductive Ethics in an Age of Technology, London, Ontario, February 1989. 137. Commercial Surrogacy. The Heart of the Matter: Harnessing Human Invention, University of Western Ontario, Faculty of Law London, Ontario, September 1988.

Françoise BAYLIS (23 March 2020) Page 39 of 53 REFEREED ABSTRACTS/POSTERS (11) 1. Krahn T, Baylis F. Assessing disclosure elements of IVF consent documents: 1991, 2004, 2014. Canadian Fertility and Andrology Meeting, Halifax, Nova Scotia, October 2015. 2. McLeod C, Baylis F. The Ethics of Asking IVF Patients to Donate Fresh Embryos to Stem Cell Research. Canadian Fertility and Andrology Meeting, Ottawa, Ontario, November 2006. 3. Krahn T, Baylis F. The Ethics of PGD for BRCA1 and 2, and HNPCC Genes. Canadian Fertility and Andrology Meeting, Ottawa, Ontario, November 2006. 4. Baylis F, Mélancon M. J. Embryonic Stem Cell Research in Canada: Shifting Tides. Stem Cells: What Future for Therapy? Scientific Aspects and Bioethical Problems; World Federation of Catholic Medical Associations. Augustinianum Institute, Rome, Italy, September 2006. 5. Mélancon M. J, Baylis F. Canadian Updated Guidelines for Human Pluripotent Stem Cell Research: Continuity and Discontinuity. Stem Cells: What Future for Therapy? Scientific Aspects and Bioethical Problems; World Federation of Catholic Medical Associations. Augustinianum Institute, Rome, Italy, September 2006. 6. Ram, N, Baylis F, Mélancon, M. J, De Braekeleer, M. Guidelines for embryonic stem cell research in CF: two countries, two similar views. 28th European CF Conference, Crete, Greece, June 2005. 7. Johnston, J., & Baylis, F. (2003). What happened to gene therapy? Analyzing recent adverse events from an ethical and political standpoint. Molecular Therapy, 7, S342; American Society for Gene Therapy, Washington, D.C., June 2003. 8. Brunger F, Baylis F. Cross-talk in Chimera Research. Abstracts GE3LS Symposium, Montréal, Québec, February, 2003. 9. Brunger F, Baylis F. Cross-talk in Chimera Research. Abstracts Stem Cell Network Annual General Meeting 2002. 10. Baylis F. Ethical Implications of Gene Therapy, Program and Proceedings of CFBS 2002; S*: 106. 11. Fernandez CV, Gordon KE, Van den Hof, MC, Taweel S, Baylis F. Attitudes of Pregnant Women to Cord Blood Stem Cell Collection, Testing and Donation. Proceedings of ASCO 2001; 20: 18a. (5% contribution)

CAREER AWARDS

Year Title Granting Agency Amount 2011- Impact Ethics: Making a Difference Canada Research Chair 1,400,000 2018 2004- Novel Genetic Technologies and Canada Research Chair 1,400,000 2011 Inter-generational Justice

RESEARCH AWARDS

Year Title Granting Agency Amount Role 2017- Implementation of a maternal CIHR 199,993 Co-Applicant 2019 pertussis immunization program: (PI D. improving coverage among Inuit MacDougall) women 2017 Development of Reference Wellcome: Global $7,234 (US) Collaborator (PI Documents to Incorporate Forum on Bioethics in R. Palacios) Pregnant Women in Vaccine Research Fellowship Clinical Development Plans 2016 Human gene editing: At the cutting Royal Society of $2,755.80 Principal edge Canada Applicant 2016- Research Ethics in the Americas NIH Fogarty Faculty 2021 International Center PI: F. Luna Training Program 2015 Alzheimer’s and Aging: Finding our Royal Society of $2,975 Co-Principal way forward together Canada Applicant

Françoise BAYLIS (23 March 2020) Page 40 of 53 2015 Bioethics and the Market in Brocher Foundation One month Principal Lemons Switzerland accommodat Applicant ion, meals and office 2015 Eggs and embryos for research Mitacs Globalink Salary for Principal summer Applicant student 2015 Patient Motivation to Participate in Dalhousie University $16,000 Principal Phase 1 (Ebola and Influenza) Applicant Vaccination Trials 2014 Growing Knowledge Translation Dalhousie University $37,500 Project Lead Components of Dalhousie Health & Wellness Research 2014 Eggs and embryos for research Mitacs Globalink Salary for Principal summer Applicant student 2012- Impact Ethics: Making a Difference Canadian Institutes of $25,000 Principal 2013 Health Research Applicant 2012- Café Scientifique: The Human Egg Canadian Institutes of $3,000 Principal 2013 Trade Health Research Applicant 2011- Impact Ethics: Making a Difference Dalhousie University $476,687 Principal 2018 (support for CRC) Applicant 2011- A Comparative Study of Assisted Canadian Institutes of $345,399 Principal 2014 Human Reproduction Patients’ Health Research Applicant Views about the Donation of Eggs and Embryos for Scientific and Clinical Research 2011- Family-Making: Contemporary Canadian Institutes of $20,000 Principal 2012 Ethical Challenges Health Research Applicant 2010- Let Conscience be their Guide? Canadian Institutes of $240,297 Co-Applicant 2013 Conscientious Refusals in Health Research (PI: C. McLeod) Reproductive Health Care 2009- Treating Alzheimer’s disease: Canadian Institutes of $3,000 Principal 2010 What to take, and who to trust? Health Research investigator 2009- Brain Matters: New Directions in CIHR $25,000 Principal 2010 Neuroethics NSHRF $3,500 Investigator Dalhousie University $13,500 IRCM $2,000 NRC $1,500 Other $4,000 2009- Brain Matters: New Directions in Greenwall $5,000 (US) Co-Principal 2010 Neuroethics Foundation Investigator (w J.S. Robert) 2008 Neuroethics and Identity Brocher Foundation 1 month Principal accommodat investigator ion and office 2007- Pandemic Planning and Canadian Institutes of $130,347 Principal 2009 Foundational Questions of Justice, Health Research investigator the Common Good and the Public Interest 2006- States of Mind: Emerging Issues in Canadian Institutes of $1,376,500 Principal 2011 Neuroethics Health Research Investigator

Françoise BAYLIS (23 March 2020) Page 41 of 53 2005- Therapeutic Hopes and Ethical Canadian Institutes of $472,348 Principal 2009 Concerns: Clinical Research in the Health Research Investigator Neurosciences 2005 States of Mind: Emerging Issues in Canadian Institutes of $5,000 Principal Neuroethics (LoI) Health Research Investigator 2004- Novel Genetic Technologies and Dalhousie University $271,000 Principal 2011 Inter-generational Justice (support for CRC) Investigator 2004- Big-Picture Bioethics: Policy- Australian Research $339,658 Co-investigator 2008 making and Liberal Democracy Council (AUD) (PI: S. Dodds) 2004- Ethical Frameworks for Health Canadian Institutes of $193,898 Co-investigator 2007 Policy: Apprisal, Appraisal and Health Research (PI: N. Kenny) Applications 2004 Development Support, Nova Scotia Health $6,010 Co-project Neuroethics New Emerging Team Research Foundation Leader (with Grant J.S. Robert) 2004 Big-Picture Bioethics: Policy- University of $15,000 Co-investigator making and Liberal Democracy Wollongong (AUD) (PI: S. Dodds) 2003- Towards Single Embryo Transfer Canadian Institutes of $3,349,040 Collaborator 2008 in the Human Health Research ($459,000) (PI: T. Kennedy) 2003- Frozen Human Embryos in Associated Medical $18,200 Principal 2004 Research: A Survey of Canadian Services Inc. Investigator IVF clinics 2001- Stem Cell Genomics and Network of Centres of $21,100,000 Co-investigator 2007 Therapeutics Network Excellence (NCE) (SD: R. Worton) 2001- -Sources of Material in Human -Stem Cell Network [$127,785] -Principal 2003 Stem Cell Research Investigator

2003- -The Model Systems Strategic -Stem Cell Network [$251,232] -Co-Project 2005 Research Network Leader (with J.S. Robert) 2003- -Our Cells/Ourselves: The Ethics -Stem Cell Network [$161,240] 2005 of Embryonic Stem Cell Research -Co-Project Leader (with J.S. Robert) 2001- Gene Therapy for Neurological Canadian Institutes of $1,300,000 Co-investigator 2004 Disease Health Research ($96,000) (PI: G. Karpati) 2001- Justice for All: Novel Genetic Canadian Institutes of $40,970 Principal 2002 Technologies and Obligations to Health Research Investigator Future Generations 2000- Ethnicity, Citizenship, Family: NIH, National Human $460,000 Project Advisor 2002 Identity After the Human Genome Genome Research (US) (PI: C. Elliot) Project Institute 2000- Our Cells/Ourselves: Human Associated Medical $15,000 Principal 2001 Biotechnology, Ethics and Public Services Inc. Investigator Policy in the New Millennium 2000- Attitudes of Pregnant Women to IWK Grace Research $14,275 Co-investigator 2001 Cord Blood Stem Cell Collection, Services (PI: C Testing and Banking Fernandez) 1999- Human Cloning and Dalhousie University $3,692 Principal 2000 Intergenerational Justice Investigator 1999 Bioethics and Health Law in CIHR SSHRC-CHSRF $39,923 Co-investigator (PI: S. Sherwin)

Françoise BAYLIS (23 March 2020) Page 42 of 53 1997- Enhancement Technologies and SSHRC $135,000 Co-investigator 2000 Human Identity (PI: C. Elliott) 1997- Enriching the COPS Curriculum Dalhousie University, $13,400 Principal 1999 Through Integration: Genetics, Research and Investigator Communication, Ethics and Law Development Fund of the Division of Medical Education 1997 Research on Gene Transfer: Dalhousie Medical $7,116 Principal Ethical Considerations Research Foundation Investigator 1997- Assent and Dissent in Research IWK Grace Health $10,000 Principal 1998 Involving Children Centre Foundation Investigator HSC Foundation $10,000 SSHRC $9,812 AMS $5,000 MRC $5,000 NCI $2,000 1996- SBC/SHHV Standards for Clinical Greenwall $316,000 Member 1998 Ethics Education & Consultation Foundation (US) (PI: S. Younger US bioethics centres and B. Arnold) and networks 1994 A Feminist Analysis of the University of $5,000 Principal Concepts of Abuse, Illness and Tennessee-Knoxville (US) Investigator Cultural Difference Faculty Research Award 1993- Feminist Health Care Ethics SSHRC $120,000 Co-investigator 1997 (PI: S. Sherwin) 1993- Paediatric Ethics: Theoretical Social Sciences and $119,750 Co-investigator 1996 Foundations as Realized in Post- Humanities Research $100,000 (PI: A. Lynch) graduate Medical Education Council, and AMS 1992- Educating Healthcare Ethics FIPSE, US $340,000 Faculty 1995 Committees Department of (US) (PI: S. Spicker) Education 1991- Ethics Consultation in Health Care Social Sciences and $70,000 Principal 1994 Humanities Research Investigator Council 1987- Health Care Ethics Project AMS; Ivey Fund; $100,000 Faculty 1990 UWO (PI: A. Lynch)

CIHR TRAINING PROGRAMS

Year Title Amount Role 2002- Ethics of Health Research and $1,717,375 Co-investigator 2008 Policy Training Program (CIHR) (PI: M. McDonald) 2002- Ethics of Health Research and $300,000 Co-investigator 2004 Policy Training Program (PI: M. (NSHRF) McDonald) 2002- CIHR Strategic Training Initiative $2,176,508 Mentor 2008 in Research in Reproductive (PI: W. Fraser) Health Sciences (STIRRHS) 2002- CIHR Training Program in Health $1,638,861 Mentor 2008 Law and Policy (PI: J. Downie)

Françoise BAYLIS (23 March 2020) Page 43 of 53

INFRASTRUCTURE GRANTS

Establishment of an Intellectual Commons for interdisciplinary research in bioethics.

Year Funding Source Amount Role 2004- Canada Foundation for Innovation: Innovation Fund $109,700 Principal 2008 Investigator 2004- Nova Scotia Research and Innovation Trust $109,700 Principal 2008 Investigator 2004- Dalhousie Faculty of Medicine $49,301 Principal 2008 Investigator

Establishment of the Canadian Centre for Vaccinology (Halifax) with laboratories for basic, translational, and multidisciplinary research and facilities for human challenge studies

Year Funding Source Amount Role 2004- Canada Foundation for Innovation: Innovation Fund $2,251,893 Co-investigator 2008 (PI: SA Halperin) 2004- Office of Economic Development, Government of Nova $2,263,309 Co-investigator 2006 Scotia (PI: SA Halperin) 2004- IWK Health Centre and other partners $1,126,340 Co-investigator 2008 (PI: SA Halperin) 2004- Canada Foundation for Innovation: Research Hospital $2,176,726 Co-investigator 2008 Fund (PI: SA Halperin)

RESEARCH CONTRACTS

1. Baylis, F. UNESCO Avicenna Prize for Ethics in Science. January 2017. 2. Baylis, F. Public Health Ethics 101. Ottawa: Policy and Partnership Division, Office of Public Health Practice, September 2010-February 2011. 3. Baylis, F. Procréation assistée: Expert ethics report for the Canadian government in reference regarding the Assisted Human Reproduction Act S.C. 2004, c.2. Ottawa: Ministère de la justice: Attorney General of Quebec v. Attorney General of Canada, July 2006-March 2007. 4. Baylis, F., & Downie J. Directory of researchers. Ottawa: Industry Canada, Canadian Biotechnology Secretariat, July 2006-March 2007. 5. Baylis, F., Ram N, & Reid L. Evaluating UNESCO document "Elaboration of the declaration on universal norms on bioethics: fourth outline of a text" in a Canadian context [Canadian Commission for UNESCO]. Ottawa: Health Canada, December 2004-January 2005. 6. Baylis, F. Assisted human reproduction: Pre-implantation genetic diagnosis, cloning, stem cells and human rights. Ottawa: Department of Justice, Human Rights Law Section, February-March 2004. 7. Downie, J., Baylis, F., Gibson, E., & Hadskis, M. Rules for human DNA banks: A Canadian and international comparative analysis. Ottawa: Health Canada, October 2003. 8. Baylis, F., Ireland, A., Kaufman, D., & Weijer, C. Protecting human research subjects: Case-based learning for Canadian research ethics boards and researchers. Ottawa: National Council on Ethics in Human Research, November 2000. 9. Baylis, F. & Ginn, D. Ethical and legal issues relating to post-exposure prophylaxis (PEP) for possible non-occupational exposure to HIV. Ottawa: HIV/AIDS Policy Coordination and Program Division, Health Canada and The NAMES Project/Le project de Noms, September 1998.

Françoise BAYLIS (23 March 2020) Page 44 of 53 10. Downie, J. & Baylis, F. Tri-council policy statement on ethical conduct for research involving humans: A review of the requirements with respect to research involving women and other systematically disadvantaged groups. Ottawa: Women's Health Bureau, Health Canada, January 1998. 11. Baylis, F. Joint policy statement: Ethical issues in assisted reproduction. Ottawa: Society of Obstetricians and Gynaecologists of Canada and Canadian Fertility and Andrology Society. Journal of SOGC 1999, 21: nos 1-5. http://www.scribd.com/doc/9205495/Joint-Policy-Statement, November 1997. 12. Baylis, F. Assisted reproductive technologies: Informed choice. Ottawa: Royal Commission on New Reproductive Technologies. 1991-1992.

RESEARCH BRIEFS / EXPERT TESTIMONY

1. Proposed regulations and the related Guidance Document: Interpretation of the Proposed Regulations under the Assisted Human Reproduction Act (Guidance Document). Written report to Health Canada [Vanessa Gruben, Alan Cattapan, Angela Cameron, Karen Busby, Davinder Singh, Stefanie Carsley, Isabel Côté, Katy Fulfer, Kévin Lavoie, Kathleen Hammond, Angel Petropanagos, and Pamela White] January 10, 2019. 2. Discussion Document (Proposed Regulations for the Assisted Human Reproduction Act). Written report to Health Canada [with Alana Cattapan]. September 9, 2017. 3. Revisions to 2nd Edition of the Tri-Council Policy Statement (2014) – Research Involving Human Cells and Cell Lines. Written report Panel on Research Ethics [with Marcus McLeod]. December 19, 2017. 4. Revisions to 2nd Edition of the Tri-Council Policy Statement (2014). Written report to Panel on Research Ethics [with Trudo Lemmens and Matthew Herder]. February 7, 2017. 5. Prepublication of proposed regulations to support the Assisted Human Reproduction Act. Written report to Health Canada [with Jocelyn Downie]. November 27, 2016. 6. CIOMS Guideline 19: Pregnant women and lactating women as research participants. Written submission to CIOMS. March 1, 2016. 7. Comments on Proposed Amendment (Annex A) to CAN/CSA Z900.2.1-12. Written report to Canadian Standards Association. September 15, 2015. 8. CIOMS Guideline 15: Pregnant and lactating women as research participants. Written report to CIOMS [with Robyn MacQuarrie]. May 25, 2015. 9. Bill 100, Universities Accountability and Sustainability Act to Nova Scotia Legislature Law Amendments Committee. Oral presentation and written report. April 30, 2015. 10. Conscientious Objection to College of Physicians and Surgeons of Ontario, regarding proposed changes to policy 5-08 “Physicians and the Ontario Human Rights Code”. Written report [with Carolyn McLeod, Jocelyn Downie, Emma Ryman, and Alana Cattapan]. February 20, 2015. 11. Conscientious Objection to College of Physicians and Surgeons of Ontario, regarding proposed changes to policies 4-07 “Physician behaviour in the professional environment” and 5-08 “Physicians and the Ontario Human Rights Code” Written report [with Carolyn McLeod, Jocelyn Downie, Alana Cattapan, Georgia Lloyd-Smith and Jacquelyn Shaw]. August 1, 2014. 12. Incorporation of CIHR Updated Guidelines for Human Pluripotent Stem Cell Research. 2nd Edition Tri- Council Policy Statement (2010). Written report to Panel on Research Ethics. January 15, 2014. 13. Revisions to 2nd Edition of the Tri-Council Policy Statement (2010). Written report to Panel on Research Ethics. January 15, 2014. 14. Round Table Discussion on Payment of Plasma Donors in Canada – Summary Report. Written report to Office of Policy and International Collaboration, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada [with Jocelyn Downie and Matthew Herder] July 25, 2013. 15. Consultation sur les activités de procréation assistée au Québec. Written report to Commissaire du Québec [with Ryan Tonkens] June 12, 2013. 16. Post-marketing Trials. Standing Senate Committee on Social Affairs, Science and Technology. Oral Presentation. Ottawa, November 8, 2012 17. Recommendation on the Status of Scientific Researchers (adopted by the General Conference of UNESCO at its 18th session on 20 November 1974, 18 C/Resolution 40) Comments prepared for the Canadian Commission for UNESCO. Ottawa, July 10, 2012.

Françoise BAYLIS (23 March 2020) Page 45 of 53 18. Clinical Trial Registration. Standing Senate Committee on Social Affairs, Science and Technology. Written report [with Matthew Herder and Trudo Lemmens]. June 11, 2012. 19. Study on prescription pharmaceuticals in Canada: Clinical trials. Standing Senate Committee on Social Affairs, Science and Technology. Oral Presentation. Ottawa, May 10, 2012. 20. Draft Health Canada “Guidance Document on the Inclusion of Women in Clinical Trials”. Written report [with Susan Sherwin] March 5, 2012. 21. Administrative Review of Assisted Human Reproduction Canada. Standing Committee on Health. Oral Presentation. Ottawa, November 16, 2010. 22. Study on Canada’s Pandemic Preparedness. Standing Senate Committee on Social Affairs, Science and Technology. Oral Presentation. Ottawa, October 27, 2010. 23. Revised Draft 2nd Edition Tri-Council Policy Statement. Several written reports on proposed revisions. Panel on Research Ethics. January 15, 2010; February 15, 2010; February 25, 2010. 24. Draft 2nd Edition Tri-Council Policy Statement. Several written reports on proposed revisions. Panel on Research Ethics. March 6, 2009; March 31, 2009 25. Report of the Working Group of IBC on Human Cloning and International Governance SHS/EST/CIB- 15/08/CONF.502/2. Written report for the Canadian Commission for UNESCO, Sectoral Commission, Natural, Social and Human Sciences [with Robin Pierce] 15 October 2008. 26. Assisted Human Reproduction (Section 8 Consent) Regulations. Government of Canada, Senate Committee on Social Affairs, Science and Technology. Oral Presentation. Ottawa, January 31, 2007. 27. Assisted Human Reproduction (Section 8 Consent) Regulations. Government of Canada, Standing Committee on Health. Oral Presentation. Ottawa, December 12, 2006. 28. Yeung et al. v. Capital District Health Authority et al. Supreme Court of Nova Scotia. Affidavit and Oral Expert Testimony. Halifax, November 16, 2006. 29. The Regulation of Assisted Human Reproductive Technologies and Related Research: A Public Health, Safety and Morality Argument. Written Expert Testimony for the federal government of Canada in the matter of Attorney General of Quebec v. Attorney General of Canada. Province of Quebec Court of Appeal. No. 500-09-015177-041 C.A. August 2006. 30. Response to Proposed Text for the Assisted Human Reproduction (Section 8) Regulations. Written report to Health Canada [with Jocelyn Downie, Elaine Gibson, Matthew Herder and Lynette Reid], November 27, 2005. 31. Evaluating UNESCO Document “Elaboration of the Declaration on Universal Norms on Bioethics: Fourth Outline of a Text” in a Canadian context, Canadian Commission for UNESCO. Oral Presentation. Ottawa, February 7, 2005. 32. Bill C-6 An Act respecting assisted human reproduction and related research. Government of Canada, Senate Committee on Social Affairs, Science and Technology. Oral Presentation. Ottawa, February 26, 2004. 33. Bill C-13 and Stem Cell Research: Embryos, Clones and Chimaeras. Friendship Group of Parliamentarians for UNESCO. Oral Presentation. Ottawa, February 5, 2003. 34. Bill C-13 An Act respecting assisted human reproduction. Government of Canada, Standing Committee on Health. Oral Presentation. Ottawa, November 19, 2002. 35. Pluripotent Stem Cell Research: The Ethical Issues. "Breakfast on the Hill" for parliamentarians and senators sponsored by the Humanities and Social Sciences Federation. Oral Presentation. Ottawa, October 18, 2001. 36. Assisted Human Reproduction. Government of Canada, Standing Committee on Health. Oral Presentation. Ottawa, May 31, 2001. 37. Sawatzky v. Riverview Health Centre. Expert witness: Two written reports submitted. “Deciding for Others” and “The Futility Debate.” March 17, 1999. 38. Research Involving Human Embryonic Material: Ethical Considerations. National Bioethics Advisory Commission (NBAC). Oral Presentation. Washington, D.C., January 19, 1999. 39. Tri-Council Working Group. Code of Ethical Conduct for Research Involving Humans. Oral and Written Presentations. Toronto, February 26, 1997.

ACADEMIC SERVICE

ACADEMIC ASSOCIATION BOARD SERVICE

Françoise BAYLIS (23 March 2020) Page 46 of 53  International Association of Bioethics (Member, Board of Directors), 2017-19.  Royal Society of Canada, Academy I, (Academic Secretary), 2012-15.  Royal Society of Canada, Awards and Recognition Committee, (Member), 2012-15.  Royal Society of Canada, Atlantic Steering Committee (Chair), 2012-15.  Royal Society of Canada, Scientific Advisory Committee on Expert Panels, (Member), 2009-15.  Royal Society of Canada Atlantic Steering Committee, (Member) 2008-12.  International Network on Feminist Approaches to Bioethics, Nominating Committee, (Chair), 2008.  International Network on Feminist Approaches to Bioethics, (Advisory Board Member), 2006-08.  International Network on Feminist Approaches to Bioethics, (Co-coordinator), 2004-06.  American Society for Bioethics and Humanities, Clinical Ethics Task Force, (Member), 2000-01.  Society for Health and Human Values/Society for Bioethics Consultation (SHHV/SBC), Task Force on Standards for Clinical Ethics Consultation, (Member) 1996-98.  Society for Bioethics Consultation (SBC), (Executive), 1995-97.  Canadian Bioethics Society (CBS), (Secretary-Treasurer), 1989-91.

UNIVERSITY COMMITTEES  Senate Honorary Degrees Committee, Dalhousie University, 2016-19  Scholarly Panel to Examine Lord Dalhousie’s History on Slavery and Race, 2016-19 https://www.dal.ca/news/2017/01/19/considering-lord-dalhousie-s-legacy-on-race.html  Research Ethics Appeal Board, Dalhousie University, 2009-21  Committee on Aboriginal and Black/African Canadian Student Access and Retention 2014-15  Senate, Dalhousie University, 2013-19  CRC Renewal Committee, Rene Lyons, 2010  Search Committee, Bioethics Department, Dalhousie University, 2008-2009  TJ Murray Visiting Scholar in Humanities Committee, Dalhousie University, 2003-06 (Chair, 2005-06)  Appointments Committee for Research Associate, Health Law Institute, Dalhousie University, 2003  PhD Nursing Program Review Committee, Dalhousie University, 2002-03  Tier II Canada Research Chair in Bioethics Search Committee, Dalhousie University, (Chair) 2000-01  Research Review Coordinating Committee, Dalhousie University, 1998-99  Review and Search Committee for Associate Dean, Medical Research Services, Dalhousie University, 1997-98  Head’s Advisory Committee, Dept. of Philosophy, University of Tennessee, 1994-96  Faculty Search Committee, Department of Philosophy, University of Tennessee, 1994-95  Centre for Applied and Professional Ethics, University of Tennessee Knoxville, 1993-96

HOSPITAL COMMITTEES  Research Ethics Board, IWK Health Centre, 2004-06  Research Ethics Board, Queen Elizabeth II Health Sciences Centre, 2000-01  Assisted Reproduction Advisory Committee, Department of Obstetrics and Gynaecology, IWK Health Centre, 1999-2001  Committee on HIV Screening and Coding, IWK Health Centre, 1999-2001  Maritime Hereditary Cancer Program, IWK-Grace Health Centre, 1998  Ethics Committee, Hospital for Sick Children, 1991-93  Education Subcommittee of the Ethics Committee, Hospital for Sick Children, 1991-93  Research Ethics Board, Hospital for Sick Children, 1991-93  Bioethics Committee, Dept. of Obstetrics and Gynaecology, Toronto Hospital, 1992-93  Embryo Freezing Committee, Dept. of Obstetrics and Gynaecology, University Hospital, 1992

SCHOLARLY REVIEW ACTIVITIES Program Review  Appraisal Consultant, PhD Program in Human Studies at Laurentian University for the Ontario Council on Graduate Studies, Sudbury Ontario, 2010.

Françoise BAYLIS (23 March 2020) Page 47 of 53  Faculté de Médecine et des sciences de la santé, Centre D’étude et de Formation « Santé, Éthiques et Sociétés » Université de Sherbrooke, 2005  National Research Council (NRC) Biotechnology Program, 2001  National Council on Ethics in Human Research (NCEHR) REB Site Visit Program, 1998-2001

Grants Panels  Canadian Institutes of Health Research (CIHR), Michael Smith Prize in Health Research (for Health Services and Systems and Population Health Research) 2009, 2010  Social Sciences and Humanities Research Council (SSHRC), Philosophy Committee, 2007  Fonds de recherche sur la société et la culture (FQRSC), 2005  College of Reviewers, Canada Research Chairs (CRC), 2002-present  Social Sciences and Humanities Research Council (SSHRC), Doctoral Fellowships, 2002-03  Stem Cell Network, Scientific Review Committee, 2002-03  Canadian Institutes of Health Research (CIHR) Health Ethics, Law and Humanities Grants Panel 2000-02  Social Sciences and Humanities Research Council (SSHRC) and Canadian Institutes of Health Research (CIHR) Design Grants Committee, 1999

Ad Hoc Grant Peer Review  Alberta Heritage Foundation for Medical Research (AHFMR)  Associated Medical Services Inc. (AMS)  Canada Council for the Arts  Canadian Institutes for Health Research (CIHR)  Canadian Institutes of Health Research (CIHR) Michael Smith Prize  Cancer Research and Education (CaRE)  Centre for Studies in Religion and Society, Faculty Fellowship Award  Peer Reviewed Orthopaedic Research Program (PRORP)  Nova Scotia Health Research Foundation (NSHRF)  Royan International Research Award  Social Sciences and Humanities Research Council (SSHRC) of Canada  Unitd Kingdom, Nuffield Foundation  United Kingdom, Wellcome Trust  United States, Department of Defense/CDMRP (Congressionally Directed Medical Research Programs)

Ad Hoc Manuscript Review  AJOB primary research  Annals RCPSC  Bioethics  Broadview Press  Cambridge University Press  Canadian Journal of Public Health  Canadian Journal of Women and the Law  Canadian Medical Association Journal  Canadian Public Policy/Analyse de Politiques  Developing World Bioethics  Elsevier  Encyclopedia of Applied Ethics  Ethics & Behavior  Harvard University Press  Hastings Center Report

Françoise BAYLIS (23 March 2020) Page 48 of 53  Hypatia  Institute of Medicine (U.S.)  Johns Hopkins University Press  Journal of Clinical Ethics  Journal of Law, Medicine & Ethics  Journal of Medical Ethics  Journal of Obstetrics and Gynaecology Canada  Journal of Social Philosophy  Journal of Women’s Health  Kennedy Institute of Ethics Journal  MIT Press  Neuroethics  Regenerative Medicine  Science and Engineering Ethics  Yale University Press

Journal Editorial/Advisory Boards  Feminist Philosophy Quarterly, 2014-2017  Monash Bioethics Review, 2014-present  International Journal of Feminist Approaches to Bioethics (IJFAB), 2009-2019  Bioethics, 2007-2011  Journal of Ethics in Mental Health, 2005-2012  Ethics & Behavior, 1999-2005  Medical Ethics: Policies, Protocols, Guidelines & Programs, 1996-2003  Healthcare Ethics Committee Forum, 1992-2002  Calyx: Ethical Issues in Paediatrics, Editor, 1991-1993

Tenure, Promotion and Reappointment Reviews  Jing-Bao Nie, (promotion to the rank of Professor) University of Otago, Dunedin, New Zealand, 2016.  Amrita Pande, (National Research Foundation, Rating Application), University of Cape Town, 2015.  Art Leader, (award of Emeritus Professor status) University of Ottawa, 2015.  Jennifer Parks, (promotion to the rank of Professor) Loyola University Chicago, 2012.  Kathryn Ehrich, (promotion to Senior Research Fellow) King’s College London, 2011.  Christine Overall, (Queen’s Research Chair, renewal), Queen’s University, 2010.  Michael Oldani, (tenure review), University of Wisconsin-Whitewater, 2009.  Julia Abelson, (promotion to the rank of Professor), McMaster University, 2009.  Walter Glannon, (promotion to the rank of Professor), Department of Philosophy, University of Calgary, 2009.  Paul Ford, (promotion to the rank of Associate Professor), Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2009.  Duff Waring, (promotion to the rank of Associate Professor with tenure), Department of Philosophy, York University, 2006.  Kathleen Oberle, (promotion to the rank of Professor), Faculty of Nursing, University of Calgary, 2006.  Joan McGregor (promotion to the rank of Professor), Department of Philosophy, Arizona State University, 2005.  Tod Chambers (promotion to the rank of Associate Professor with tenure), Medical Ethics and Humanities Program, The Feinberg School of Medicine, Northwestern University, 2003  Jonathan Hellmann (promotion to the rank of Professor), Department of Pediatrics, University of Toronto, 2002  Laurie Zoloth (promotion to the rank of Professor), Jewish Studies Program, San Francisco State University, 1999

Françoise BAYLIS (23 March 2020) Page 49 of 53  William Harvey (promotion to the rank of Professor), Department of Philosophy, University of Toronto, 1998  Carl Elliott (promotion to the rank of Associate Professor), Department of Pediatrics, University of Minnesota, 1997  Carol Cowell (promotion to the rank of Professor), Department of Obstetrics and Gynaecology, University of Toronto, 1993

CONFERENCE PLANNING  Member, Planning Committee, Global Forum on Bioethics in Research. Buenos Aires, Brazil, 2016.  Member, Planning Committee, International Summit on Human Gene Editing. Washington, DC, 2015.  Chair, Planning Committee, What Should be the “Business” of the University in the 21st Century? Halifax, NS, 2014.  Co-Chair, Planning Committee, Brain Matters: New Directions in Neuroethics, Halifax, NS, 2009.  Planning Committee, International Network on Feminist Approaches to Bioethics, Beijing China, 2006  Planning Committee, Maritime Health Technology Symposium, Halifax, NS, 2006  Planning Committee, Canadian Society for Women in Philosophy, Halifax, NS, 2005  Planning Committee, Canadian Bioethics Society (CBS), Halifax, NS, 2005  Peer Review, American Society for Bioethics and Humanities (ASBH), Nashville TN, 2001  Planning Committee, Canadian Bioethics Society (CBS), Halifax, NS, 1997  Chair, Planning Committee, Society for Bioethics Consultation (SBC), Cleveland OH, 1995  Peer Review, Society for Bioethics Consultation (SBC), Cleveland OH, 1995  Planning Committee, Society for Bioethics Consultation (SBC), Pittsburgh, PA, 1994  Planning Committee, Society for Bioethics Consultation (SBC), Cleveland, OH, 1993  Planning Committee, Canadian Bioethics Society (CBS), Toronto, ON, 1992  Planning Committee, Canadian Bioethics Society (CBS), Hamilton, ON, 1991

COURSES TAUGHT UNDERGRADUATE  Health Professions HPRO 4801 (Independent Study); Dalhousie University Fall 14  Biology BIOL 4807 (Special Topics in Biology); Dalhousie University (independent study) 97  Clerkship Ethics (MED III); Faculty of Medicine, Dalhousie University Spring 97; Fall 97; Fall 98; Fall 01  Ob/Gyn Clinical Clerkship (MED III); Faculty of Medicine, Dalhousie University 1999-present (monthly 1 1/2 hour tutorials)  Ethics in Medicine (Patient-Doctor Unit) (MED I); Faculty of Medicine, Dalhousie University Spring 97; Spring 98; Fall 98  Ethics in Genetics Embryology and Reproduction (MED I); Faculty of Medicine, Dalhousie University, Spring 98 – present  Philosophy PHIL 345 (Medical Ethics); University of Tennessee, Knoxville Fall 93; Spring 94; Spring 95; Summer 95; Spring 96  Rehabilitation Medicine REH 400 (Ethics in Rehabilitation); University of Toronto Fall 91, 92  Medical Ethics (331S) (MED III); Faculty of Medicine, University of Toronto Spring 91; Spring 93  Human Values in Medicine ETH 111F (MED I); Faculty of Medicine, University of Toronto Fall 90; Fall 91  Philosophy PHIL 145 (Introduction to Philosophy); University of Western Ontario, Fall 84 GRADUATE  Philosophy/Bioethics PHIL 4801/ PHIL 5801 /BIOT 5801 (Ethics and Reproductive Health Care), Spring 2014  Bioethics BIOT 5105 (Directed Reading Course in Bioethics), Summer 2009  Bioethics BIOT 5101 (Resources for Bioethicists); Dalhousie University, Winter 2006  Bioethics BIOT 5000 (Advanced Topics in Bioethics); Dalhousie University, Winter 2005

Françoise BAYLIS (23 March 2020) Page 50 of 53  Philosophy PHIL 546 (Orientation to Medical Ethics); University of Tennessee, Knoxville Spring 96  Philosophy PHIL 588 (Clinical Practicum); University of Tennessee, Knoxville Fall 95  Philosophy PHIL 544 (Topics in Applied Ethics: Feminist Health Care Ethics); University of Tennessee, Knoxville, Spring 95  Philosophy PHIL 547 (Clinical Med. Ethics); University of Tennessee, Knoxville, Spring 94  Medical Ethics; Hospital for Sick Children, Paediatric Residents Seminar (RI), Spring 92

CONTINUING EDUCATION  Canadian Public Health Association, mission to Serbia, November 2004  Integrity in Scholarly Activity Workshop, Dalhousie University, January 2003  Canadian Health Care Ethics Forum (national meeting), Senior Faculty and Program Chair, Vancouver, August 1998 (5 day retreat for faculty-in-training)  Everyday Ethics; Faculty of Medicine, Dalhousie University, Fall 1998 (4hours)  Canadian Health Care Ethics Forum (regional meeting), Senior Faculty, Halifax, October 1996 (3 day meeting for faculty-in-training)  Bioethics Interest Group; Faculty of Medicine, Dalhousie University Fall 1996; Spring 1997 (4hours)  Canadian Health Care Ethics Forum (national meeting), Senior Faculty, The Banff Centre, August 1996 (3-5 day retreat for faculty-in-training)  Faculty Development Workshop on Ethics, University of Manitoba, January 1996 (2 day workshop)  Canadian Health Care Ethics Forum (national meeting), Senior Faculty, The Banff Centre, August 1995 (5 day retreat for faculty-in-training)  Everyday Ethics; Hospital for Sick Children, December 1991 - June 1993 (monthly, 2 hour seminars)  Ethics and In Vitro Fertilization, The Michener Institute for Applied Health Sciences (ME 705), Fall 1990 and Fall 1991 (8 hour seminars)  Nursing Ethics, St. Joseph’s Health Centre, Fall 1990 (6 hours)  But is it Ethical? G1041; University of Western Ontario, Fall 1990 (4 hours)  Elderhostel, University of Western Ontario, June 1990 (4 hours)

In addition to the above, while working as an ethics consultant, I have conducted a range of educational activities in health care settings including Grand Rounds, seminars, full day workshops for residents, hospital staff and Ethics Committee members at the following health care institutions in Canada and the United States:

 Capital District Health Authority, Halifax, Nova Scotia, January 2001  Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, June 1999  Nova Scotia Hospital, Dartmouth, Nova Scotia, December 1998  St Paul’s Hospital, Vancouver, British Columbia, October 1997  IWK/Grace Health Centre, Halifax, Nova Scotia, November 1996 to August 1997  The Children's Hospital, Columbus, Ohio, February 1996  St. John's Hospital, Springfield, Missouri, November 1995  Alpena Hospital, Alpena, Michigan, (FIPSE) June 1995  St. Boniface General Hospital, Winnipeg, Manitoba, May 1995  Vancouver General Hospital, Vancouver, British Columbia, April 1995  Vanderbilt, Nashville, Tennessee, April 1994  Fitzsimons Hospital, Denver, Colorado, (FIPSE) April 1994  Health Sciences Centre, Winnipeg, Manitoba, January 1994; May 1995; January 1996  University of Tennessee Medical Center, Knoxville, Tennessee, October 1993; April 1994  Evanston Hospital, Evanston, Illinois, (FIPSE) November 1993  Williamsport Hospital, Williamsport, Pennsylvania, (FIPSE) May 1993; May 1994  Women's College Hospital, Toronto, Ontario 1993  Queen Street Mental Health Center, Toronto, Ontario 1993  Doctor's Hospital, Toronto, Ontario 1992  Mount Sinai Hospital, Toronto, Ontario 1992

Françoise BAYLIS (23 March 2020) Page 51 of 53  Toronto Hospital (General Division), Toronto, Ontario, 1991-1993  Riverside Hospital, Ottawa, Ontario, November 1989  University Hospital, London, Ontario, 1989-1992  St Joseph's Hospital, London, Ontario, 1989-1991

SUPERVISORY EXPERIENCE (55) 1. Marcus McLeod, Part-time Research Associate, Dalhousie University, October 16–May 17 2. Eluned Jones, Summer Research Student, Dalhousie University, May 16–August 16 3. Harrington Critchley, Summer Research Student, Dalhousie University, May 16–August 16 4. Lisbeth Witthof Nielsen, Part-time Research Assistant, Dalhousie University, March 16–August 16 5. Gonzalo Zurita Balderas, Mitacs Globalink student from Mexico, June 15–August 15 6. Katherine Browne, Post Doctoral Fellow, Dalhousie University, September 14–December 15 7. Angel Petropanagos, Post Doctoral Fellow, Dalhousie University, July 14–January 19 8. Khue Hua, Mitacs Globalink student from Vietnam, June 14–August 14. 9. David Snow, Research Associate/ Izakk Walton Killam Post Doctoral Fellow, Dalhousie University, February 14–June 15. 10. Alana Cattapan, Research Associate/ CIHR Post Doctoral Fellow, Dalhousie University, December 13–June 17. 11. Ashley Doyle, Research Associate, Dalhousie University, July 13–July 14 12. Rob MacDougall, Post Doctoral Fellow, Dalhousie University, September 12–December 13 13. Tamara Kayali, Post Doctoral Fellow, Dalhousie University, September 12–July 13 14. Ryan Tonkens, Post Doctoral Fellow, Dalhousie University, August 12–June 13 15. Samantha Copeland, PhD Student, Research Associate, Dalhousie University, March 12 – September 15; (Completed September 2015; official graduation May 2016) – awarded Dalhousie Faculty of Graduate Studies Thesis Award and nominated by Dalhousie for the 2016 CAGS/PROQUEST-UMI Distinguished Dissertation Award. 16. Pamela White, Research Associate, Dalhousie University, September 11–May 12 17. Ami Harbin, Post Doctoral Fellow, Dalhousie University, July 11–March 12 18. Meena Krishnamurthy, Post Doctoral Fellow, Dalhousie University, October 10–May 11 19. Serife Tekin, Post Doctoral Fellow, Dalhousie University, September 09–May 12 20. Mark Munsterhjelm, Post Doctoral Fellow, Research Associate, Dalhousie University, Nov. 09– October 10 21. Syd Johnson, Post Doctoral Fellow, Dalhousie University, September 09–June 11 22. Simon Outram, Post Doctoral Fellow, Dalhousie University, June 09–January 12 23. Tom Wallwork, Research Assistant, Dalhousie University, May 09–April 11 24. Frederic Gilbert, Post Doctoral Fellow, Dalhousie University, January 09–December 10 25. Robin Pierce, Post Doctoral Fellow, Dalhousie University, September 08–October 09 26. Julie Bull, Interdisciplinary PhD, Dalhousie University, September 08-August 09 27. Robyn McQuarrie, Interdisciplinary PhD, Dalhousie University, September 07–16 28. Gillian Crozier, Post Doctoral Fellow, CIHR Trainee, Dalhousie University, September 07–August 09 29. Victoria Seaville-Klein, Philosophy PhD Thesis Committee, Dalhousie University, September 07 30. Andrew Fenton, Post Doctoral Fellow, Dalhousie University, May 07–August 09; May 10–May 11 31. Sheri Alpert, Research Associate, Dalhousie University, September 06–May 08 32. Jennifer Bell, Research Assistant, Dalhousie University, September 06–June 07 33. Erin Power, Research Assistant, Dalhousie University, September–November 06 34. Tim Krahn, Research Associate, Dalhousie University, October 05–August 11; January 14-Sept. 19 35. Lawrence Burns, Post Doctoral Fellow, CIHR Trainee, Dalhousie University, Sept. 05–August 07 36. Caroline McInnes, Research Assistant, Dalhousie University, summers 05 and 06 37. Lynette Reid, Research Associate, Dalhousie University, September 04–May 06 38. Zubin Master, Post Doctoral Fellow, SCN Trainee, CIHR Trainee, Dalhousie University, Oct. 03– December 04 39. Gillian Nycum, Research Assistant, McGill University, October 03–December 04 40. Natalie Ram, Research Assistant, Dalhousie University, Summer 03 and September 04–July 05 41. Jennifer Brian, Research Assistant, Dalhousie University, June 03–July 2004, Summer 06 42. Josephine Johnston, Research Associate, SCN Trainee, Dalhousie University, March 02–June 03 43. Thane Plantikow, Research Assistant, Dalhousie University, November 02–June 03

Françoise BAYLIS (23 March 2020) Page 52 of 53 44. Matthew Herder, Research Assistant, Dalhousie University, August 00 – April 03; Sept 05–July 06 45. Jason S. Robert, Post-Doctoral Fellow in Philosophy, Dalhousie University, October00–June 01 46. Carolyn McLeod, Philosophy PhD Student, Dalhousie University, September 98–May 99 47. Christy Simpson, Philosophy PhD Student, Dalhousie University, September 96–May 00 48. Carolyn Ells, Philosophy PhD Student, University of Tennessee, September 95–June 96 49. Eileen Amari-Vaught, Philosophy PhD Student, University of Tennessee, September 95–May 96 50. Jennifer Heyl, Philosophy PhD Student, University of Tennessee, September 95–May 96 51. Ward Hobbs, Philosophy PhD Student, University of Tennessee, September 94–May 95 52. Lisa Eckenwiler, Philosophy PhD Student, University of Tennessee, Spring 96 53. Annette Mendola, Philosophy PhD Student, University of Tennessee, Spring 94 54. Louise Kunicki, RN and Research Associate, Hospital for Sick Children, September 92–June 96 55. Sharon Rae, Philosophy PhD Student, University of Toronto, September 92–June 93

Françoise BAYLIS (23 March 2020) Page 53 of 53